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ABSTRACT OF THE DISSERTATION

NEVER SMOKERS - ARE THEY MORE SENSITIVE TO THE RESPIRATORY
HEALTH EFFECT OF AMBIENT AIR POLLUTION?
By
Zuhair Saleh Natto
Doctor of Public Health Candidate in Epidemiology
Loma Linda University, September 2013
Synnove Knutsen, MD, MPH, PhD, Chair

Background: Several studies show an association between ambient particulate
matter (PM) and all-cause mortality. The Adventist Health and Smog 1 (AHSMOG-1)
study (N=6,338) has previously found associations between ambient air pollution and
incident chronic obstructive pulmonary disease (COPD) using the spatial interpolation
method from the three nearest fixed monitoring stations to residence and workplace.
However, few studies have assessed the risk of death among disease specific subgroups
such as those with COPD.
Objectives: The aims of this study were 1) to assess the effect of chronic
exposure to ambient air pollutants on risk of all-cause mortality among persons with
COPD and/or asthma. 2) To assess the effect of chronic exposure on ambient air
pollutants (PM2.5 and O3) and the risk of non-cancer respiratory mortality among a new
and larger cohort of Adventists from the Adventist Health and Smog Study 2
(AHSMOG-2). The study population consists of subjects who have never smoked and
who have not changed their primary residence since enrollment in the study. This study
iv

specifically assessed chronic exposure to ambient particulate and gaseous pollutants
(PM2.5 and O3) by utilizing AHSMOG-2 data and mortality data from National Death
Index (NDI) for the years 2002-2007.
Methods: Using data from the Adventist Health Study-2, a cohort of 97,000 US
and Canadian subjects, a subgroup of 43,964 never smoking subjects who had not moved
since enrollment, lived in the US, and who self-reported having been diagnosed with
either COPD and/or asthma was selected. Further, these subjects had completed a 50
page baseline questionnaire which included demographics, medical history, time spent
outdoors, exercise, smoking, and diet. A total of 102 subjects have died during an average
of 3 years and 10 months of follow-up. The Cox proportional hazard model was used for
survival analysis, adjusting for a number of potential confounders including age, race,
education, body mass index (BMI), time spent outdoors, physical exercise, and dietary
patterns. Inverse distance weighting (IDW) with interpolation to residence address was
used to estimate individual level ambient air pollution. Cumulative monthly and averages
from 12 months prior to enrollment until one month before censoring were used.
Results and Conclusion: For each 10 pg/m3 increase in PM2.5, the hazard ratio
(HR) for all-cause mortality was 2.70 (95% (Cl): 1.09-6.65) in the single-pollutant model
and 2.23 (95 % Cl: 0.99-5.03) in the two-pollutant model with O3. Elevated, but not
statistically significant associations were found with 03, either in single or two-pollutant
models (HRs and 95% Cl were 1.32 (0.74-2.36) and 1.33 (0.79-2.25) respectively). For
each 10 ppb increase in O3, the HR for any cause of death due to non-cancer respiratory
diseases was 1.93 (95% Cl: 1.31- 2.85) in the single-pollutant model and 1.95 (95% Cl:
1.32-2.87) in the two-pollutant model with PM2.5. No associations were found with PM2.5

either in single or two-pollutant models (HRs and 95 % Cl were 1.12 (0.64-1.97) and
1.21 (0.69-2.12) respectively). These findings could have implications for policy
regulations.
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CHAPTER 1
INTRODUCTION

A. Statement of the Problem
Chronic obstructive pulmonary disease (COPD) is increasing in incidence and
mortality worldwide. It is expected to be the third leading cause of death in 2020; it was
the sixth leading cause in 1990 (Raherison, 2009; Martin, 2008). Several factors will
likely play a significant role in this pattern, such as ambient particulate matter (PM) air
pollution. Many epidemiological studies have demonstrated an association between PM
air pollution and mortality from lung cancer, cardiovascular disease, and respiratory
diseases such as COPD. Several studies have investigated the relationship between air
pollution and COPD mortality, including the Harvard Six Cities Study, (Dockery et al.,
1993) which showed that cardiopulmonary mortality was significantly associated with
mean sulfates and fine particulates matter (PM) over the one-year study period. Although
there are no specific separate results specifically for COPD in this study, This study has
several strengths including such as random selection of study subjects; high response
rates (more than 70%), personal interviews with respondents at the time of enrollment,
subsequent follow-up for 12 years, and lung function measurements at baseline (Higgins
et al,2003). Exposure however was represented by one average figure for each city so that
only six air pollutant data points were used (Higgins et al., 2003).
The American Cancer Society (ACS) (Pope et al., 2002; Pope et al., 1995)found
that fine particulate and sulfur oxide-related pollution were associated with all cause,
lung cancer, and cardiopulmonary mortality, and long-term exposure to combustion-
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related fine particulate air pollution was also an important environmental risk factor for
cardiopulmonary and lung cancer mortality, but again, no results are given for risk of
COPD separately in this study, which covered 154 cities and includes extensive
information on health status, demographic characteristics, smoking history, alcohol use,
and occupational exposures. A limitation was that these subjects were enrolled by
volunteers from among their friends and relatives, so it is likely that the subjects probably
were not representative of the general population within each city. Finally, the air quality
measures were not designed for this study, but were obtained from monitors set up
previously by the U.S. Environmental Protection Agency (EPA) (Higgins et al., 2003).
The Adventist Health and Smog Study (AHSMOG) confirmed the results of the
previous studies (Harvard Six Cities & American Cancer Society). The AHSMOG-1
study (N=6,338) had previously showed associations between ambient air pollution and
COPD using the inverse distance weighted (IDW) interpolation method from the nearest
fixed monitoring station to residence and workplace zip codes. The mean age at inclusion
was 58.5 years for males and 59.2 years for females. In 1999, Abbey et al. examined
chronic exposure to air pollution mortality among 6,338 non-smoking Seventh-day
Adventist adults living in California from 1977-1992. This study described an elevated
mortality risk associated with ambient PMio for any mention of non-malignant
respiratory disease in both sexes combined (RICH. 18 95% Cl: 1.02, 1.36) (Abbey et al.,
1999), and an elevated risk of death for lung cancer mortality in both sexes combined, but
with a more marked effect in males than females (Beeson et al., 1998). The AHSMOG
study has several limitations, such as possible underreporting of alcohol and tobacco use,
using deterministic interpolations from fixed site monitors, indirect estimates of PMio
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before 1987, and the fact that multi pollutant analyses were limited to PMio, SO2, O3, and
NO2 (Beeson et ah, 1998).
Another study has evaluated the short-term health effects of air pollution on daily
mortality in four Australian cities from 1996-1999, in which more than 50% of
Australians reside (Simpson et ah, 2005). They used a similar protocol to APHEA2 (Air
Pollution and Health: A European Approach) study. There were significant effects on
total mortality, (RR=1.0284 per 1 unit increase in nephelometry [10-4.m-l], and on
respiratory mortality (RR=1.0022 per Ippb increase in O3). They concluded that air
pollutants in Australian cities have significant effects on mortality (Simpson et ah, 2005).
Although several epidemiological studies suggest a link between air pollutants
and adverse COPD outcomes, there is a lack of evidence on the contribution of long
term ambient air pollution exposures, whether particulate or gaseous, contribute to an
increased risk of death among non- and never-smokers with COPD, a susceptible
population. In addition, there are more subjects in the current database than in
AHSMOG-1, and we anticipate that it will be a more accurate measurement tool for air
pollution.
B. Purpose of the Study
The purpose of this study is twofold: 1) to assess the effect of chronic exposure to
ambient air pollutants and risk of non-cancer respiratory mortality among Seventh day
Adventists who have not changed their primary residence since enrollment into the study,
2) to assess the effect of chronic exposure to ambient air pollutants and risk of death
among the Seventh-day Adventist subpopulation who have self-reported COPD and/or
asthma at baseline and who did not change their primary residence since enrollment in
3

the study. This study will specifically assess chronic exposure of particulate and gaseous
pollutants including PM2.5 and O3 by utilizing the Adventist Health and Smog
(AHSMOG-2) Study and NDI mortality data for the years 2002-2007.
C. Research Questions
1) To what extentPMi.s and O3 contribute to an increased risk of non-cancer
respiratory mortality among never smokers in this new cohort?
2) To what extent PM2.5 and O3 contribute to an increased risk of all-cause
mortality among COPD/asthma patients who never smoked?
D. Specific Aims
1) To assess the long-term effects of PM2.5O3 on the risk of non-cancer respiratory
mortality (emphysema, bronchitis, asthma and pneumonia) among the AHSMOG-2
population with no address change during follow-up. These associations will be studied
both in single- and two-pollutant models.
2) To assess the long-term effects of PM2.5O3 on the risk of total mortality among
the sensitive subgroups of those with prevalent COPD and/or asthma and no address
change during follow-up. These associations will be studied both in single- and twopollutant models.
E. Hypotheses
1) There is an association between long-term exposure to ambient particulate air
pollution (PM2.5) and non-cancer respiratory mortality (emphysema, bronchitis, asthma,
and pneumonia) among non-smokers with no address change during follow-up.
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2) There is an association between long-term exposure to ambient gaseous
pollution (O3) and non-cancer respiratory mortality (emphysema, bronchitis, asthma, and
pneumonia) among non-smoking persons with no address change during follow-up.
3) There is an association between long-term ambient PM2.5 and total mortality
among the sensitive subpopulation with chronic obstructive pulmonary disease (COPD)
and/or asthma.
4) There is an association between long-term ambient gaseous pollution ozone
(O3) and total mortality among the sensitive subpopulation with chronic obstructive
pulmonary disease (COPD) and/or asthma.
F. Significance to Epidemiology
The results of this study will be important given the effect of air pollutants in the
US. The findings may provide new information about how air pollutants, specifically
particulate matter (PM2.5) and ozone (O3) are related to non-cancer respiratory or all
cause mortality. This study will add to the existing literature regarding air pollutants and
mortality and will provide data that may have important implications in the development
of new policy.
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CHAPTER 2
LITERATURE REVIEW

A. Definitions
Chronic obstructive pulmonary disease (COPD) is defined as “ a chronic
respiratory disorder that progresses slowly and is characterized by an obstructive
ventilatory pattern, which is rarely reversible, and can lead to chronic respiratory failure”
(Raherison & Girodet, 2009). Guidelines from the World Health Organization (WHO),
Global Obstructive Lung Disease (GOLD) (Pauwels, Buist, Calverley, Jenkins, & Hurd,
2001) and American Thoracic Society (ATS)/European Respiratory Society (ERS) (Celli
& MacNee, 2004) describe it as a disease characterized by airflow limitation and is not
fully reversible. It is also defined as the ratio of FEVi (forced expiratory volume in 1
second) to FVC (forced vital capacity) being less than 70% when measured with postbronchodilator lung function (Celli, Halbert, Isonaka, & Schau, 2003).
COPD has three components: chronic bronchitis, which is defined as “the
presence of chronic or recurrent increase in bronchial secretions sufficient to cause
expectoration. The secretions are present on most days for a minimum of 3 months per
year for at least two successive years and cannot be attributed to other pulmonary or
cardiac causes. Hyper-secretion can occur in the absence of airflow limitation” (Viegi et
al., 2007); emphysema, which is defined as “anatomically by permanent, destructive
enlargement of airspaces distal to the terminal bronchioles without obvious fibrosis”
(Viegi et al., 2007); and lastly, chronic respiratory failure, which is defined by “the
existence of chronic obstructive bronchitis with hypoxemia” (Raherison & Girodet,
2009).
6

COPD can coexist with asthma and may develop a mixture of asthma and COPDlike inflammation (Lange, Pamer, Vestbo, Schnohr, & Jensen, 1998); however, although
the pathogenesis and pathology are very different in these two diseases it may be difficult
to differentiate them clinically in some individuals. COPD is characterized by increased
numbers of neutrophils, CDS + lymphocytes, and not fully reversible airflow limitation,
while asthma is characterized by CD4 + lymphocytes, eosinophils, and reversible airflow
limitation (GOLD, 2010). For this reason, most of the articles do not include asthma as a
type of COPD. However, the Dutch hypothesis proposed by Orie and colleagues
maintains that “various forms of airway obstruction, such as asthma and chronic
bronchitis, should not be considered as separate diseases but rather as different
expressions of a single diseases entity, a chronic, non-specific lung disease” (Bleecker,
2004).

B. Epidemiology of COPD
Chronic obstructive pulmonary disease (COPD) is increasing in incidence, with
210 million globally living with the disease (Halpin & Miravitlles, 2006). The actual
number may be higher because the disease is frequently underestimated in young
populations, misclassified in some patients (Kohler, Fischer, Raschke, & Schonhofer,
2003), and misdiagnosed in developed and developing countries (Halpin & Miravitlles,
2006).
The prevalence of COPD shows large variability in many areas, depending on the
definition of airway obstruction (Viegi et al., 2000). The problem with the ERS criterion
in percentage ([FEV1]/ [VC]) is that it tends to lower the prevalence compared with using
the clinical criterion (GOLD stage I+). For example, the prevalence of airway obstruction
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in adults aged 25-73 years from a general population sample from North Italy dropped
from 18.3% with the clinical criterion to 11% with the ERS criterion for the same
population (Viegi et ah, 2000). Celli et al. found the prevalence of COPD among a US
national adult representative sample of the National Health And Nutrition Examination
Survey (NHANES) III, to range from 7.7% for self-reported to 16.8% with GOLD stage
1+ (Celli, 2008; Celli et al., 2003). The prevalence among current White smokers was
slightly higher among males (14.2%) than females (13.6%) (Mannino, Ford, & Redd,
2003). Less than 50% of diagnosed individual based on a doctor’s diagnosis (Mannino,
Ford, et al., 2003).
We can see geographical disparities in the articles that used the clinical criterion
(GOLD) (Gooptu, Ekeowa, & Lomas, 2009). There is a higher prevalence of COPD in
Southeast Asia (11.4%), followed by the Pacific (9%), Europe (7.4%) and America
(4.6%), but it should be noted that there is an absence of clear data available from many
parts of the world, such as Africa, Australia, and the Mediterranean countries (Gooptu et
al., 2009).
Overall, the prevalence of COPD shows an increase in trend with time and we
expect this trend to continue (Mannino & Buist, 2007). Several factors contribute to this
pattern, including improved medical diagnosis, an increased interest in health among the
general public, an absence of an effective cure for COPD, changes in the environment
and life style, and increased life expectancy and an increase in the elderly population
(Mannino & Buist, 2007). As we will see, despite the decrease in cigarette smoking, these
factors, in addition to several others, together play an important role in the increased
prevalence of COPD.
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C. Morbidity and Mortality of COPD:
1. Morbidity
COPD is more common in developed countries than in developing parts of
the world (Lopez et ah, 2006). It is projected to be the third leading cause of death
worldwide in 2020, rising from sixth place in 1990 (Raherison & Girodet, 2009). In the
US, COPD was the fourth leading cause of death during 2006 with a total of 120,970
deaths (Martin et ah, 2008).
COPD is also associated with many co-morbid conditions such as cardiovascular
disease, pulmonary diseases, and cancer. Holguin et al. found in a national representative
sample of 47 million hospitalized patients from 1979 to 2001 that COPD was more likely
to coexist with pneumonia, hypertension, heart failure, ischemic heart disease, or
vascular disease in the same hospitalized patients compared with age-adjusted non COPD
discharge patients (Holguin, Folch, Redd, & Mannino, 2005). He found also age adjusted
in-hospital-mortality was higher among COPD patients for pneumonia, hypertension,
heart failure, and thoracic malignancies compared with non-COPD patients.
In a study done by Soriano and colleagues in the UK, among 2,699 COPD
patients and 7,931 asthma patients with a matched cohort (case-cohort study), incidence
of myocardial infarction and angina were nearly doubled among COPD patients, but
angina prevalence was less in the asthma group compared with patients without asthma
(RR=1.4) (Soriano, Visick, Muellerova, Payvandi, & Hansell, 2005). Similar findings
have been reported in a study of 38 patients with COPD and non COPD matched
controls, in which the prevalence of metabolic syndrome was higher among the COPD
group (47% versus 21%) (Marquis et al., 2005). COPD patients are also at risk for
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depression and anxiety, four to five times higher than the control group (Di Marco et ah,
2006). It is also more common in women and associated with less muscle mass (Di
Marco et ah, 2006).
Asthma accounts for about 10 million outpatient visits and 500,000
hospitalizations in the US alone(25% of all emergency room visits) (NCHS, 2001). Most
of them are children (44%) with 3 days average length of stay in a hospital (NCHS,
2000). It is more common among African Americans compared with Whites (3:1) and is
the third cause of hospitalizations among children (NCHS, 2003; NIAID, 2001).
2. Mortality
COPD was the underlying cause of death for 126,005 persons older than
25 years in the US in 2005, according to the Centers for Disease Control and Prevention
(CDC) Morbidity and Mortality Weekly Report (MMWR, 2005, 2008). It was the
underlying cause for 116,494 deaths in 2000 which means an increase of 8% (MMWR,
2005, 2008). During 2000 to 2005, the death rate for women increased by 23%, but
overall the death rate was higher for men compared with women in each year (Celli,
2008; Lopez et ah, 2006).
Asthma is associated with far fewer deaths than COPD. In the U.S., there are
more than 4,000 deaths due to asthma each year (11 deaths per day) (NCHS, 2001).
Asthma also acts as a “contributing factor” for another 7,000 deaths each year (NCHS,
2001). Most of these deaths are avoidable with proper treatment and care. Women (65%)
and African Americans (3 times compared with Whites) are most vulnerable to asthma
mortality (NCHS, 2001; NIAID, 2001). The death rates of asthma overall have increased
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more than 50% among all genders, age groups, and ethnic groups since 1980 (NCHS,
2001).
D. Risk factors and causes of COPD:
1. Cigarette Smoking
The most important risk factor for most respiratory diseases, including
COPD, is tobacco smoking. COPD is the second leading cause of death from smoking,
accounting for 0.97 million deaths worldwide after cardiovascular disease (1.69 million
deaths), and before lung cancer (0.85 million deaths) (Ezzati & Lopez, 2003).
A 40 years follow up study on British male doctors is one of the most important
studies that showed the link between tobacco smoking and COPD. It found that COPD
mortality was seven times higher in smokers than in nonsmokers, and the overall
mortality rate for individuals from age 35 to 69 years increased by 41% among light
smokers, 50% among heavy smokers, and 20% among non-smokers (Doll, 1999; Doll,
Peto, Boreham, & Sutherland, 2004; Doll, Peto, Wheatley, Gray, & Sutherland, 1994).
The Obstructive Lung Disease in North Sweden (OLIN) study reported that 50% of
smokers eventually develop COPD, as defined according to the GOLD guidelines
(Rennard & Vestbo, 2006). This finding means half of smokers are at risk for developing
COPD. The OLIN study calculated that the population attributable risk of COPD for
smoking (also called the etiological fraction, or the maximum proportion of disease cases
within a defined population that can be attributed to exposure to a specific factor if the
factor is causative of that disease) at 45% (95% Cl; 29-58%) in the 46-77-year age
group (Rennard & Vestbo, 2006). When researchers used the British Thoracic Society
criteria for the diagnosis of COPD, which are considerably more stringent than the
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GOLD criteria (The COPD Guidelines Group of the Standards of Care Committee of the
BTS, 1997), the population attributable risk was 50% (95% Cl 28-67%) (Rennard &
Vestbo, 2006). The third NHANES III study researchers calculated the population
attributable risk at 44% (95% Cl 38-50%) (Mannino, Buist, Petty, Enright, & Redd,
2003).
Several studies have shown that smokers are at higher risk of decreased FEV1;
there is also a dose - response relationship between the intensity of smoking and the
decline in FEV1 (Capelli et ah, 1999; Hnizdo, Sullivan, Bang, & Wagner, 2002; Lim et
ah, 2000; Stoller & Aboussouan, 2005; Takizawa et ah, 2001). The possible relationship
mechanism may be when cigarette smoke directly stimulates various types of cells such
as macrophages (Blanc et ah, 2009; Mannino, Ford, et ah, 2003) and epithelial cells of
the airways (Liu et ah, 2007), which contribute to increased production of mediators and
cytokines which maintain the inflammatory reaction. Other theories have been suggested,
namely that tobacco smoking causes an imbalance in proteases/antiproteases, leading to
the destruction of compounds in the extracellular matrix, elastin in particular (Buist et ah,
2007). An additional hypothesis suggested a permanent antagonism between the toxicity
of oxidants present in cigarette smoke and the antioxidant immune system (Ait-Khaled et
ah, 2007). However, smoking is an important risk factor and the percentage of active
smokers among COPD patients overall varies from 40% to 70% depending on location
(Raherison & Girodet, 2009).
Other forms of smoking, such as pipe smoking and cigar smoking, were found to
be associated with higher mortality rates from COPD (RR 2.98 and 1.45, respectively)
(Henley, Thun, Chao, & Calle, 2004; Iribarren, Tekawa, Sidney, & Friedman, 1999).
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Environmental tobacco smoke (ETS) exposure also is suggestive, but not sufficient to be
a risk for COPD. In US adults aged 55-75 years, an increased risk of COPD was
observed with elevated home (OR 1.55) and work ETS exposure (OR 1.36) (Eisner et al.,
2005).
2. Occupational Exposure
The incidence of COPD is much higher in workers who are exposed to
fumes, chemicals, and dust from vegetables, cotton, bacterial or fungal toxins, mining,
smelter, plants and iron and steel industry, the wood industry, and the building trade. It
is also higher in rural areas among several occupations where workers are exposed to
organic particles, such as in the textile industry and in the industrial environment
(Hnizdo et al., 2002). The risk of development of COPD due to occupational exposure
has been estimated at 10- 19% among smokers, and at 31-50% for nonsmokers
(Bergdahl et al., 2004; Raherison & Girodet, 2009; Viegi et al., 2007). Workforce data
and the Carcinogen Exposure (CAREX) database estimated there were 318,000 deaths
from COPD and nearly 3,7 million disability-adjusted life-years (DALYs) for COPD
due to exposure to occupational airborne particulates in 2000 (Mannino, Ford, et al.,
2003).

The worker who is exposed to both smoking and occupational factors has been
found to have a markedly increased risk of COPD (Blanc et al., 2009). Blanc et al found
that those who self-reported exposure to vapors, gas, dust, or fumes on the longest held
job had double the odds of COPD compared to those with neither occupational exposures
nor smoking risk (OR 1.98; 95% Cl 1.26-3.09). When both smoking and occupational
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factors combined the risk of COPD increased to a 14-fold, whereas smoking alone was
associated with a 7-fold increased risk.
3. Socioeconomic Status and Lifestyle
Socioeconomic status includes several indicators such as income,
education, type of work and housing conditions. A low socioeconomic level is an
important risk factor for the development of COPD (Ait-Khaled et ah, 2007; Buist et ah,
2007; de Torres, Campo, Casanova, Aguirre-Jaime, & Zulueta, 2006; Liu et ah, 2007). A
Chinese study found that the overall prevalence of COPD in China was 9.4%, but was
significantly higher in rural Yunyan than in urban Liwang (12.0% vs. 7.4%, p = 0.01).
This may be partly due to other risk factors such as age, sex, smoking, lifetime exposure
to environmental tobacco smoke, occupational exposure to dusts, cooking fuels and so
on. However, overall prevalence of active cigarette smoking in Yunyan was significantly
higher than in Liwang (38.4% vs. 35.1%). The prevalence of COPD in men was
significantly higher than in women (15.9% vs. 4.8%; p =0.01). However, the prevalence
of COPD was significantly higher among women in rural Yunyan than in urban Liwang
in both the total population and in the non-smoking subpopulation (7.1% vs. 3.0%, and
7.2% vs. 2.5%, respectively, although there were more smoking women in Liwang than
in Yunyan (9.5% vs. 0.5%; Liu et ah, 2007). This association was detected even after
adjusting for smoking and other risk factors (Liu et ah, 2007). This suggests that other
important factors might have contributed to COPD, particularly among non-smoking
women in Yunyan, but this was not mentioned by the authors. However, there are also
several factors that may exist from childhood which together may have an impact on
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adult respiratory function, including diet, the risk of infection, and occupational exposure
(Raherison & Girodet, 2009).
4. Gender
Male gender was believed to be a risk factor due to higher smoking and
occupational exposures compared with women. However, increasing numbers of women
have started smoking in recent years. Some authors have proposed that women may
actually be at higher risk of developing COPD due to the severe impact of smoking on
lung function among females, and the higher risk of hospital admission due to COPD
among women after controlling for smoking (de Serres, 2002; de Torres et ah, 2005;
DeMeo, 2007).
5. Genetic Factors
The genetic association with COPD depends mainly on alpha-1-antitrypsin
deficiency (Taraseviciene-Stewart & Voelkel, 2008). This is a hereditary defect of two
alleles of the inhibiting protein positioned in the gene locus of the section of chromosome
14q32.1. The odds ratio associated with this deficiency ranges from 1.5 to 5 (Sandford,
Weir, & Pare, 1997). It can be present as a homozygote phenotype PiZZ which is the
more severe form or in the heterozygote form (DeMeo, 2007; Raherison & Girodet,
2009). Some other genetic alterations such as alpha-2-macroglobulin, cystic fibrosis
transmembrane regulator gene, mircosomal epoxide hydrolase, vitamin D binding
protein, the blood serotype group genes, and single nucleotide polymorphisms in
glutathione S-transferase pi and matrix metalloproteinase have also been associated with
a higher risk of developing COPD (DeMeo & Silverman, 2004; Schikowski et ah, 2005;
Viegi et ah, 2007).
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6. Family History
Several studies suggests that the risk of COPD development in relatives of
smokers or ex-smokers with early-onset COPD is about three times higher than that of a
control population due to reduced lung function (Alfaro-Moreno, Nawrot, Nemmar, &
Nemery, 2007; Mukhamedieva & Bogomolov, 2009).
7. Air Pollution
Many studies have found a relationship between air pollution and the
occurrence of asthma, bronchitis, and emphysema (Dockery & Pope, 1994; Dockery et
ah, 1993; Jerrett et ah, 2009; Krewski et ah, 2005; Pope, 1989, 1991; Pope, Dockery,
Spengler, & Raizenne, 1991; Wietlisbach, Pope, & Ackermann-Liebrich, 1996). The
design of each of these studies, and their strengths and weaknesses will be explained in
detail in the health impact section (see page 23 below) based on the type of study.
Overall, the relationship between air pollution and some respiratory ailments is similar to
cigarette smoking by causing airway inflammation which in turn destroys lung tissue.
The burning of fuel creates by-products such as smoke and invisible irritants which
contaminate our atmosphere and pose health threats to humans. These by-products may
also be derived from photochemical reaction, furniture, building materials, biological
organisms, and fibers (Wordley, Walters, & Ayres, 1997).
Indoor air pollution in homes is as great a risk for COPD as outdoor air exposure,
particularly in developing countries. It is estimated that risk associated with indoor air
exposure accounts for 35% of cases (Raherison & Girodet, 2009). The concentration of
ETS, PM, NO2 ,CO, and volatile organic compounds and biological allergens can be
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several times higher indoors than outdoors due to biomass and coal burning for cooking
and heating (Raherison & Girodet, 2009).
The etiological and pathogenic role of air pollution in terms of risk factors is not
well known (Liu et al., 2007; Morgan, Corbett, & Wlodarczyk, 1998). In the past few
years, several research studies have been conducted to better understand this relationship,
and these studies provide significant improvements in our knowledge of the effects of air
pollution on cardiopulmonary disease.
The studies conducted until now have provided strong evidence that long-term
exposure to air pollution is a risk factor for cardiopulmonary disease and cancer,
including several studies from the AHSMOG-1 cohort (Abbey et al., 1998; Abbey,
Hwang, Burchette, Vancuren, & Mills, 1995; Abbey et al., 1999; Abbey, Petersen, Mills,
& Beeson, 1993; Beeson, Abbey, & Knutsen, 1998; L. H. Chen et al., 2005; McDonnell,
Nishino-Ishikawa, Petersen, Chen, & Abbey, 2000). The earlier studies focused more on
PMio and ozone, while the recent studies focus on ozone and PM2.5, which more easily
able penetrates deeper into the respiratory system.
E. Epidemiology of Asthma
According to the WHO, it is estimated that 235 million people worldwide suffer
from asthma (WHO, 2009). About 10% (20 million) are living in the U. S., which means
that 1 in 15 Americans suffer from asthma (CDC, 1999). Asthma has been increasing
recently among all age, sex, and racial groups (CDC, 1999). It is the most common
chronic condition among children under the age of 18 ( about 5 million) (NAAS, 2000;
NIAID, 2001), and is more common among adult women and male children than adult
men and female children (NCHS, 2003). African Americans have a slightly higher
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asthma prevalence than Caucasians (NIAID, 2001). Racial differences in asthma
prevalence are highly correlated with poverty, urban air quality, indoor allergens, and
lack of patient education and inadequate medical care (NIAID, 2001).
F. Morbidity and Mortality of Asthma:
1.

Morbidity:
Asthma accounts for about 10 million outpatient visits and 500,000

hospitalizations in the US alone, and 25% of all emergency room visits (NCHS, 2001).
Most are children (44%), with an average hospital stay of three days (NCHS, 2000). It is
more common among African Americans compared with Whites (3:1) and the third cause
of hospitalizations among children (NCHS, 2003; NIAID, 2001). The number of noninstitutionalized adults who currently have asthma is 18.7 million (8.2%), with around
17.0 million total visits to physician offices in 2010 (CDC, 2012).
2. Mortality
The number and rate of asthma deaths are not comparable before and after
1999, because in 1999 the population standard used to calculate age-adjusted death rates
was changed from the 1940 population to the 2000 population. In addition, the tenth
revision of international classification of diseases (ICD-10) replaced ICD-9 in coding and
classifying mortality data from death certificates. Overall, the number of deaths due to
asthma has declined by 26% since 1999, even after the ICD-10 revision has been taken
into account (CDC, 2010).
In 2007, 3,447 people died of asthma in the US alone. Approximately 63% of these
deaths occurred in women. The female age-adjusted death rate was 33% higher than the
rate seen in males (The age-adjusted death rate was 1.1 per 100,000). It was higher
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among the Black population than among the White population (2.5 versus 0.9 per
100,000, respectively) (CDC, 2010). Most deaths occurred in adults over 85 years of age
(152 deaths in children under 15 years, compared to 659 among adults over 85 years).
The death rate was the highest among those 85 and over (12.0 per 100,000) with a much
lower death rate among those 75-84 years of age — 4.4 per 100,000 (CDC, 2010).
G. Risk Factors and Causes of asthma:
There are several risk factors related to asthma, but these are more related to
childhood asthma such as prenatal tobacco smoke, diet and nutrition, breastfeeding,
socioeconomic status, infections and use of antibiotics, family history, allergic
sensitization, male gender, gene - environmental interaction, exposure to environmental
tobacco smoke or to animals (Subbarao, Mandhane, & Sears, 2009).
In this dissertation we focus on air pollution among adults age 30+. Adults have
less asthma compared with children and the adult asthma form may have persisted from
childhood, occurred as a relapse of earlier childhood asthma or may be true adult-onset
asthma with no symptoms in early life (Butland & Strachan, 2007; Wenzel, 2006). Most
of adulthood asthma cases may have environmental (especially occupational) causes with
or without allergen sensitization such as car painting (isocyanates), hairdressing (various
chemicals), domestic and commercial cleaning (cleaning solutions), health care
professions (latex) and baking (flour dust) (Bakerly et al., 2008; Eagan, Gulsvik, Hide, &
Bakke, 2002; Kogevinas et al., 2007; Le Moual, Kennedy, & Kauffmann, 2004). The risk
of these known substances to cause occupational asthma has been associated with RR
1.6, and a 95% [Cl] 1.1-2.3; the risk associated with exposure to an acute inhalation
event, such as fire, mixing of cleaning agents or a chemical spill was found to be even
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higher (RR 3.3, 95% Cl 1.0-11.1, p = 0.05) (Subbarao et al., 2009). Other risk factors
include air pollution, which though it may affect adult asthma is more often a factor
worsening pre-existing asthma rather than a cause of incident asthma. Atopy is a risk
factor but less common with increasing age (C. H. Chen, Xirasagar, & Lin, 2006;
Johnston et al., 2006). Specific drug treatments such as p-blockers, non-steroidal, anti
inflammatory or use of hormone replacement therapy in women may play role as risk
factors (Subbarao et al., 2009).
H. Air Pollution Sources:
The U.S. Environmental Protection Agency (EPA) has established National
Ambient Air Quality Standards for six common air pollutants. These "criteria pollutants"
are commonly found all over the U.S, and include particle pollution (particulate matter),
ground-level ozone, carbon monoxide, sulfur oxides, nitrogen oxides, and lead. Of these,
particulate matter and ground-level ozone are the most widespread health threats.
1. Ozone
Ozone (O3) is created in the atmosphere by the reaction of organic
hydrocarbon compounds and oxides of nitrogen (e.g.NO, NO2, NO3, N2, etc.) in the
presence of energy from the sun. It is also created in the stratosphere by UVC radiation
from the sun acting on diatomic oxygen. It is beneficial when it serves as a protective
layer from the sun’s harmful ultraviolet radiation in the stratosphere (10 to 30 miles
above ground). However, it has harmful effects when it occurs in the troposphere (0 to 7
miles above ground) and has been associated with premature death, asthma, bronchitis,
heart attack, and other cardiopulmonary problems (Mudway & Kelly, 2004).
2. Particulate matter
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Particulate matter (PM) occurs as solid or as particles on liquid drops in the air:
pollens, dust, and aerosol from combustion activities as well as meteorological conditions
such as windblown dust (Cesaroni, Badaloni, Porta, Forastiere, & Perucci, 2008). It can
be created directly from fossil fuel combustion, an industrial process, and transportation,
or from miscellaneous anthropogenic and natural sources such as fugitive dust,
agriculture and forestry, wind erosion, wildfires, and managed burning (Muir, Longhurst,
& Tubb, 2006). It can also be produced indirectly when gaseous pollutants such as SO2
and NO2 undergo transformation to fine particles. It differs chemically and physically
based on location, source, time of year, and climate, and is classified into two sizes:
coarse, which are between 3-30 pm in aerodynamic diameter, and fine, which are < 2.5
pm in aerodynamic diameter or less (Mouli, Mohan, & Reddy, 2006; Toledo et ah,
2008). The fine particles tend to deposit deep in the terminal bronchioles and alveoli of
the lung, while the larger particles tend to deposit in the upper airways (Muir et al.,
2006).
3. Sulfur Oxides
Sulfur dioxide (SO2) is a highly reactive gas known as oxide of sulfur. It
has many major sources, such as fossil fuel combustion at power plants (66%) and other
industrial facilities (29%). It has also minor sources such as extracting metal from ore and
the burning of sulfur-containing fuels by locomotives, large ships, and off-road
equipment. SO2 has several harmful effects such as bronchoconstriction and increased
asthma symptoms (Chen, Gokhale, Shofer, & Kuschner, 2007).
4. Nitrogen Dioxide
Nitrogen dioxide (NO2) is an oxidizing agent that reacts with the moisture
in the air from nitric acid and toxic organic nitrates. It also forms nitric oxide (NO) from
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motor vehicles, fossil fuel-fired power plants, and industrial boilers due to high
temperature (Chen et ah, 2007). NO2 has several harmful effects, such as airway
inflammation in healthy people, and increased respiratory symptoms in people with
asthma (Pope et ah, 1999).
5. Carbon Monoxide
Carbon monoxide (CO) is a colorless, odorless gas emitted from
incomplete combustion processes, mainly from mobile sources. It can cause harmful
health effects because it has high affinity with hemoglobin, which will reduce oxygen
delivery to the vital body's organs (like the heart and brain) and tissues. At high
concentrations, carbon monoxide can cause toxicity and death.
6. Lead
Lead (Pb) is a metal found naturally in the environment and in
manufactured products. Motor vehicles (such as cars and trucks) and industrial sources
are the major sources of its emissions. It has many side effects, and once taken into the
body is distributed through blood and accumulates in bones. It can affect kidney
function, and the immune, reproductive, developmental, cardiovascular, and nervous
systems based on the exposure concentration. Lead exposure also has a similar effect as
carbon monoxide, since can affect the oxygen carrying capacity of the blood. The most
common side effects of lead exposure are neurological effects in children and
cardiovascular effects (e.g., high blood pressure and heart disease) in adults. It can also
cause behavioral problems, learning deficits, and lowered IQ in infants and young
children.

22

I. Health Impacts
Epidemiological studies suggest several harmful effects for air pollution on
respiratory disease such as COPD and asthma. Therefore, this review will focus on
summarizing studies about these conditions.
1. Time- Series Studies
Some studies have also used Daily Time Series (DTS) to explore
associations between short term changes in mortality and air pollution while controlling
for a number of weather-related variables such as seasonality (Dockery et al., 1993; Levy,
Hammitt, & Spengler, 2000; Samet, Zeger, et al., 2000). These studies can be divided as
the following:
a. Particulate matter less than 10 jug in diameter (PMjo): Most time-series
studies have observed changes in daily mortality in the order of 0.5-1.5% associated with
a 10 pg/m increase in concentrations of inhalable particles (less than 10 pg in diameter)
(Schwartz & Morris, 1995). Several studies have made similar findings (Burnett et al.,
1995; Dominici et al., 2006; Poloniecki, Atkinson, de Leon, & Anderson, 1997;
Schwartz, 1997, 1999). Samet et al., assessed the effects of five major outdoor air
pollutants on daily mortality rates in 20 of the largest cities from 1987 to 1994 (Samet,
Dominici, Curriero, Coursac, & Zeger, 2000), using a two-stage analytic approach that
pooled data from multiple locations. In the first stage, “a separate log-linear regression of
the daily mortality rate on air-pollution measures and other confounders was fitted to
obtain estimates of the relative rate of mortality associated with the pollution variable and
the degree of statistical uncertainty for each of the 20 cities.” In the second stage, “the
estimates of the relative rates were combined for all cities (after adjustment for the
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various levels of uncertainty) to obtain an overall estimate.” They found the estimated
increase in the relative rate of death from all causes due to the level of PM 10 was 0.51%
(0.07, 0.93) and 0.68% (0.20, 1.16) for increased respiratory mortality.
In Europe, the Air Pollution and Health: A European Approach (APHEA) project
has focused on the short term effect of PMio. It consists of both APHEA-1 (the older
study) and APHEA-2 (the most recent study). Atkinson et al., studied eight cities within
the APHEA 2 group (Atkinson et al., 2001) and found associations between PMio
particles and daily counts of emergency hospital admissions after adjusting for
environmental factors and temporal patterns. The percentage change in mean number of
■j

daily admissions per 10 pg /m increase inPMio was 1.1% (0.3, 1.8) for asthma (among
15-64 year olds). A positive association was found between PMio and admissions for
both COPD and asthma. Katsouyanni et al., studied over 43 million people and 29
European cities within APHEA-2 (Katsouyanni et al., 2001) and found that the estimated
increase in the daily number of deaths for all ages due PMio was 0.6% (0.4, 0.8); it was
slightly higher for the elderly.
b. Particulate matter less than 2.5 nm in diameter (PM2.5): Studies from
the U.S. have shown an increase in COPD mortality with increase outdoor levels of PM2.5
(Dominici et al., 2006; Ostro, Broadwin, Green, Feng, & Lipsett, 2006; Samet, et al.,
2000). Dominici et al. (2006) estimated the risks of cardiovascular and respiratory
hospital admissions associated with short-term exposure to PM2.5 for Medicare enrollees
by using a national database comprising daily time-series data for 1999 through 2002 on
hospital admission rates for 204 US urban counties with 11.5 million Medicare enrollees
(aged >65 years) living an average of 5.9 miles from a PM2.5 monitor (Dominici et al.,
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2006). There was a short-term increase in hospital admission rates associated with PM2.5
'i

for heart failure (the greatest change) with a 1.28% increase in risk per 10-pg/m (95%
Cl, 0.78-1.78), and COPD with a RR-0.91 (95% Cl, 0.18-1.64) (Dominici et al., 2006).
Another study conducted in California provided evidence of an association between daily
counts of mortality and ambient PM2.5 in nine heavily populated California counties using
data from 1999 through 2002 (Ostro et al., 2006). The researchers examined these
associations among several subpopulations for all-cause and cause-specific mortality
(respiratory, cardiovascular, ischemic heart disease, and diabetes); they found a 0.6%
(95% Cl, 0.2-1.0%) increase in all-cause mortality with each lO-gg/m change in 0-1 day
average PM2.5 concentration; 0.6% (95% Cl: 0.0-1.1%) increase in cardiovascular
mortality; and 2.2% (95% Cl: 0.6-3.9%) increase in respiratory mortality. For an
average of 2 days, mortality increased by 0.3% (95% Cl: 0.1-0.7%) and 1.3% (95% Cl:
0.1-2.6%) for cardiovascular and respiratory conditions, respectively(Ostro et al., 2006).
c. Ozone (O3) In the APHEA-2 project, the effects of ambient daily ozone
concentrations on mortality were studied independent of SO2 and PM10 (Gryparis et al.,
2004). A total of 23 cities/areas were included over at least 3 years since 1990. Effect
estimates were obtained at 2 stages for each city with city-specific models then combined
using second-stage regression models. An increase in the 1-hour ozone concentration by
ppb was associated with a 0.33% (95% Cl, 0.17-0.52) increase in the total daily number
of deaths, 0.45% (95% Cl, 0.22-0.69) increase in the cardiovascular deaths, and 1.13%
(95% Cl, 0.62-1.48) increase in respiratory deaths. The same results were found when
using the 8-hour ozone estimate (Gryparis et al., 2004).
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Similar, but not significant findings, were found in “The 20 Largest Cities” study
from 1987 to 1994, in which increases in ozone levels of 10 ppb were associated with
0.41 percent (95 % posterior interval, -0.20 to 1.01 percent) increased relative rates of
death during the summer, when ozone levels are highest, but not during the winter (-1.83
percent (95 % posterior interval,-2.69 to -0.96 percent) (Samet, et al., 2000). In this study
the researchers used a posterior interval, which is different from confidence interval.
The nine French cities study provided data on daily air pollution between 1990
and 1995, and assessed for total mortality, cardiovascular mortality, and respiratory
mortality (Le Tertre et al., 2002). After controlling for trends in seasons, calendar effects,
influenza epidemics, temperature, and humidity, the short-term effects of air pollution on
mortality was assessed. Significant and positive associations between total daily deaths in
these cities and several air pollution indicators were found, including ozone with RR
1.027 (95% Cl = 1.3, 4.1). Similar results were obtained for cardiovascular mortality
(RR=1.031 027 [95% Cl = 1.005, 1.055])), but not for respiratory mortality (RR 1.008,
95% [Cl = 0.952, 1.062]) (Le Tertre et al., 2002).
A study in Helsinki, Finland was undertaken to determine the short-term
associations of ozone with cause-specific cardiorespiratory mortality and morbidity by
age groups (Halonen et al., 2010). Daily levels of ozone were measured from 1998 to
2004. The study group was divided into elderly people (> 65 years) and adults (15-64
years). All models were adjusted for PM2.5 and Poisson regression was used for the
analyses. There was a positive association between ozone and hospital admissions for
asthma-chronic obstructive pulmonary disease (COPD) in elderly people (9.6%; 95% Cl
'j

2.0% to 17.8% at 0-day lag for 25 mg/m increase in ozone). Respiratory mortality,
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including all respiratory diseases (ICD-10=J00-J99), pneumonia (ICD-10=J12-J15, J16.8,
J18) and pooled asthma-COPD (ICD-10=J41, J44-J46) did not show any associations
with O3. However, the current day PM2.5, when adjusted for O3, was associated with all
cardiovascular mortality among the elderly population. The researchers concluded that
positive associations were stronger for ambient ozone with asthma visits among children
and with pooled asthma/COPD admissions among elderly people as compared with
cardiovascular outcomes (Halonen et ah, 2010).
Another large study assessed the short-term effects of air pollution in each of ten
large European cities (London, Paris, Lyon, Barcelona, Milan, Krakow, Lodz, Wroclaw,
Poznan, and Bratislava)controlling for season, influenza epidemics, and meteorological
events (Zmirou et al., 1998). For Eastern Europe, the pooled relative risks of daily deaths
■j

from cardiovascular conditions were 1.02 [95% = 1.01-1.04] for a 50 pg/m increment in
the concentration of black smoke; whereas in western European cities, there was a RR of
1.04 (95% Cl = 1.01-1.06) for a 50 pg/m3 increment increased in sulfur dioxide levels.
For respiratory diseases, these figures were 1.04 (95% Cl = 1.02-1.07) and 1.05 (95% Cl
= 1.03-1.07), respectively in the eastern of Europe. All these associations were not found
in the five central European cities (Krakow, Lodz, Wroclaw, Poznan, and Bratislava).
Eight-hour averages of ozone were also moderately associated with daily mortality in
western European cities for respiratory conditions (relative risk = 1.06; 95% Cl = 1.021.10) (Zmirou et al., 1998).
Only one study has not been able to find any significant relationship between
ozone alone and respiratory mortality (Saez et al., 2002). In the study of 7 Spanish cities,
which were included in the Spanish Multicentric Study of the Effects of Air Pollution on
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Mortality (EMECAM project), generalized additive models were used when analyzing
the effect of single and multiple pollutants (Saez et ah, 2002). Mortality indicators
included daily total mortality from all causes excluding external causes, daily
cardiovascular mortality, and daily respiratory mortality. The relative risks for causespecific mortality were nearly twice as much as that for total mortality for all the
photochemical pollutants (nitrogen dioxide and ozone). Ozone was independently related
only to cardiovascular daily mortality, but no statistically significant relationship between
photochemical air pollutants and respiratory mortality was found (Saez et al., 2002).
Bell, et al., performed a meta-analysis of 144 effect estimates from 39 time-series
studies, and estimated pooled effects by different age groups, cause-specific mortality,
and concentration metrics. It includes the National Morbidity, Mortality, and Air
Pollution Study (NMMAPS), a time-series study of 95 large U.S. urban centers from
1987 to 2000. They found strong evidence of a short-term association between ozone and
mortality. This relationship was stronger with cardiovascular and respiratory mortality
compared with all-cause mortality, among elderly compared with younger persons, and
current-day ozone exposure compared with previous days (Bell, Dominici, & Samet,
2005).
d. Strengths and Weaknesses: Single site time series studies have been
criticized because of exposure measurement error, significant variations of the air
pollution impacts and the heterogeneity of the statistical method used in different studies
(Katsouyanni et al., 1997; Samet, et al., 2000). Multiple site time series studies have tried
to minimize the disadvantages of single site series, but they still have issues in the
validity of exposure assessment, due to a lack of personal O3 measurements (McKone,
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Ryan, & Ozkaynak, 2009). Overall, these types of studies are more focused on the short
term health effects of air pollution on all-cause mortality, respiratory mortality, and
hospital admissions at a community or ecological level.
2. Case - Crossover Studies
This type of study is another method for estimating short-term health
effects of air pollution. Several investigators used this method to understand the
relationship between air pollution and COPD (Cheng, Tsai, Wu, Chen, & Yang, 2007;
Sauerzapf, Jones, & Cross, 2009; Tecer, Alagha, Karaca, Tuncel, & Hides, 2008; Xu,
Zborowski, Arena, Rager, & Talbott, 2008).
In Kaohsiung, Taiwan, researchers investigated the association between air
pollutant levels and hospital admissions for pneumonia for the period of 1996-2004
(Cheng et ah, 2007). After controlling for weather variables, day of the week, seasonality,
and long-term time trends, the relative risk of hospital admissions in the single-pollutant
models was 1.21 (95%CI, 1.15-1.28) for PMio on warm days (= 25 degrees C), and 1.57
(95%CI, 1.50-1.65) on cool days (< 25 degrees C). In England, Sauerzapf et al. (2009)
recorded a total of 1,050 COPD admissions during a 1 year time interval for patients
attending three hospitals in the county of Norfolk, between January 2006 and February
2007(Sauerzapf et ah, 2009). Same day air pollution concentrations of several air
pollutants such as carbon monoxide, nitric oxide, ozone and fine particulates were
registered. After adjusting for temperature, pollen and respiratory infections, there was a
strong positive association between COPD admissions and levels of CO with an increase
in the odds of admission by 2% for each 10 p/m3 increase, NO (17%) and N02(22%), but
not with particulate matter.
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Others have reported an association between air pollution and admissions for
asthma and other respiratory diseases among children younger than 15 years old (Tecer et
al., 2008). In this study conducted in Zonguldak, Turkey, odds ratios for the admissions
associated with several sizes of particulate matter (PMio, PM2.5, and PM10-2.5) were
assessed. The adjusted odds ratios for exposure to PM2.5 with an increment of 10 pg/m3
were 1.15 (95%CI, 0, 99-1.34) and 1.21 (95%CI, 1.10-1.33), respectively, for asthma
and allergic rhinitis with asthma. PM 10 and PM 10-2.5 showed very similar odds for asthma
1.18 (95% Cl, 1.01-1.39), and 1.14 (95% Cl, 1.03-1.26), respectively.
In the US, a case-crossover study was performed to assess the association
between daily air pollution and cardiorespiratory hospitalizations among Pittsburgh
residents ages 65 years and older for the period of 1996 through 2000 (Xu et al., 2008).
Significant associations were observed between the fourth 4th quartile compared with 1st
quartile in PM10 and cardiorespiratory hospitalizations (odds ratio [OR]: 1.12; 95% Cl:
1.02-1.23) and cardiovascular hospitalizations only (OR: 1.13; 95% Cl: 1.01-1.26), but
not with respiratory hospitalization only (OR: 1.11; 95% Cl: 0.92-1.35).
Overall, these case-crossover studies found a positive relationship between
ambient air pollution and daily hospital admissions (Cheng et al., 2007; Tecer et al.,
2008; Xu et al., 2008).
3. Cohort Studies
a. Short Term Exposure Studies Short-term exposure (less than 3 years) to
elevated particulate matter and air pollution in general has been shown to exacerbate
chronic cardiovascular and respiratory diseases in several studies, including studies along
the Meuse River Valley in Belgium and in Donora, Pennsylvania (Ciocco & Thompson,
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1961). Wichman reported that in 1953, Logan observed that 80-90 percent excess deaths
were associated with short-term air pollution episodes from December 5th - 8th, 1952.
Using information on cause-of-death from death certificates, an increase in
cardiovascular and respiratory disease was seen within two weeks following the episode.
Furthermore, Wichmann (Wichmann, 1989) and Anderson (Anderson et al., 1995)
observed increased cardiopulmonary death and hospitalizations in Germany (1985) and
England (1991), respectively, following episodes of short-term air pollution.
Another study evaluated the short-term health effects of air pollution on daily
mortality in four Australian cities from 1996-1999, where more than 50% of Australians
reside (Simpson et al., 2005). They used a similar protocol to the APHEA-2 study and
derived single-city and pooled estimates. There were significant effects on total mortality,
(RR= 1.0284 per 1 unit increase in nephelometry, and on respiratory mortality
(RR=1.0022 per Ippb increase in O3). They concluded that air pollutants in Australian
cities have significant effects on mortality (Simpson et al., 2005).
Most of the short term studies focused on its effect on cardiovascular health. A
study from Spain evaluated the short term effect of air pollution on cardiovascular
admissions in 14 Spanish cities from 1995 to 1999 (Ballester et al., 2006). Daily
emergency admissions for all cardiovascular diseases (CVD) and heart diseases (HD)
were obtained from hospital records, and the corresponding daily levels of particulates,
SO2, NO2, CO, and ozone (O3) were recorded. Short term associations were reported
between increases in daily levels of ambient particulate matter (PM10) and the number of
daily admissions for cardiovascular diseases in the 14 cities studied.
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b. Long Term Exposure Studies There are only a few large cohort studies
compared with other previous types of studies. The most important studies done in this
field are the Harvard Six Cities Study (Dockery et al., 1993), the American Cancer
Society Study (Pope et al., 2002; Pope et al., 1995), and the Adventist Health and Smog
Study (AHSMOG) (Abbey et al., 1998; Abbey et al., 1995; Abbey et al., 1999; Abbey et
al., 1993; Beeson et al., 1998; L. H. Chen et al., 2005; McDonnell et al., 2000). Those
studies have shown increased risk for general, cardiopulmonary, and cancer mortality
associated with ambient air pollution.
Perhaps the most important chronic exposure study ever to assess the impact of
air pollution on mortality is the Harvard Six Cities study, which involved a 14-16 year
prospective follow up of more than 8000 adults in six U.S. cities and controlled for age,
sex, cigarette smoking, education, body mass index, and other risk factors (Sullivan et al.,
2005). The adjusted mortality-rate ratio for the most polluted of the cities as compared
with the least polluted was 1.26 (95 % Cl, 1.08 to 1.47). Air pollution was positively
associated with cardiopulmonary mortality in current smokers 2.30 (95 % Cl, 1.56 to
3.41). Mortality was also associated with most polluted compared with the least polluted
1.37 (95 % Cl, 1.11 to 1.68). Overall mortality was most strongly associated with fine
particulate air pollution (Dockery et al., 1993). Also, cardiopulmonary mortality was
significantly associated with both mean sulfate and fine particulates over the yearlong
study period.
This study has several important strengths, such as random selection of study
subjects; high response rates (more than 70%); personal interviews with respondents at
the time of enrollment; subsequent follow-up for 12 years; and lung function

32

measurements at baseline and residential histories. The air pollution data were measured
by the original investigators who designed the Six Cities Study to cover a range of air
pollution levels across large cities. However, air pollution exposure was represented by
only one average figure for each city so that only six air pollution data points were used.
The American Cancer Society (ACS) study demonstrated an association between
ambient levels of air pollutants during the study period and the probability of death
(Schwartz, 1999).
In the CPS-2 study, Pope at al. assessed the relationship between long-term
exposure to fine particulate air pollution and all-cause, lung cancer, and cardiopulmonary
mortality (Pope et al., 1999). Vital status and cause of death data were collected by the
American Cancer Society as part of the Cancer Prevention II study, a prospective
mortality study which enrolled approximately 1.2 million adults in 1982. Participants
completed a questionnaire detailing individual risk factor data (age, sex, race, weight,
height, smoking history, education, marital status, diet, alcohol consumption, and
occupational exposures). These risk factor data for approximately 500,000 adults were
linked with air pollution data for the metropolitan areas in which they resided throughout
the U.S. and combined with vital statistics and cause of death data through December 31,
1998. The study found that fine particulate- and sulfur oxide-related pollution were
associated with all cause, lung cancer, and cardiopulmonary mortality (Pope et al., 1999).
Each 10 pg/m3 increase in fine particulate air pollution was associated with
approximately a 4%, 6%, and 8% increased risk of all-cause, cardiopulmonary, and lung
cancer mortality, respectively. Furthermore, it was suggested that long-term exposure to
combustion-related fine particulate air pollution is also an important environmental risk
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factor for cardiopulmonary and lung cancer mortality. In 2009, Jerrett et al., published
another paper using data from this study and found in single-pollutant models that
increased concentrations of either PM2.5 or ozone were significantly associated with an
increased risk of death from cardiopulmonary causes (RR=1.129, 95% Cl (1.094-1.071);
RR=1.016, 95% Cl (1.008-1.024)), respectively. In two-pollutant models, PM2.5 was no
longer associated with the risk of death from respiratory causes, including respiratory
cancer RR=0.927, 95% Cl (0.836-1.029), whereas a 10 ppb increase in ozone
concentration was positively associated with respiratory mortality with RR= 1.040
(95%CI, 1.010 to 1.067) (Jerrett et al., 2009).
This is very large cohort of study subjects which covered 154 cities. It has
extensive information on health status, demographic characteristics, smoking history,
alcohol use, and occupational exposures. A limitation was that these subjects were
enrolled by volunteers from among their friends and relatives, so it is likely that the
subjects were not representative of the general population within each city. Finally, the
air quality measures were not designed for this study; they were obtained from monitors
set up previously by the U.S. Environmental Protection Agency (EPA) as one measure
per metropolitan area in which the subjects were residents.
The Adventist Health and Smog Study (AHSMOG-1) confirmed the results of the
previous studies (Harvard Six Cities & ACS-CPS2). The mean age of subjects at
enrollment was 58.5 years for males and 59.2 years for females. Abbey et al. examined
chronic exposure to air pollution with the cause-specific mortality among 6,338 non
smoking Seventh-day Adventist adults living in California from 1977-1992. An elevated
risk was found with increasing levels of ambient PM 10 for any mention of non-malignant
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respiratory disease in both genders combined with RR=1.18 (95% [Cl]: 1.02, 1.36)
(Abbey et al., 1999). The risk of lung cancer mortality was also increased, but with a
more marked effect in males than females (Beeson et al., 1998).
The AHSMOG study (Abbey et al., 1998) also showed that an increase in the
mean concentration of SO4 of 1.6 pg/m3 was related to a 1.5% decrement in FEV1 in all
males, an increase of 23 ppb of ozone for an average of 8 hours was associated with a
6.3% decrement in FEV1 in males who had asthma, bronchitis, emphysema or hay fever
(Abbey et al., 1998). These data demonstrated that prolonged exposure to ambient ozone
is related to development of asthma and other respiratory conditions in adult males.
The AHSMOG-1 study had several limitations such as possible underreporting of
alcohol and tobacco use, interpolations from fixed site monitors, indirect estimates of
PM10 before 1987, and multipollutant analyses were limited to PM10, SO2, O3, and NO2
(Beeson et al., 1998). We think it is important to have baseline data to understand the
relationship between air pollutants and COPD/asthma to measure the actual effect
without confounding by alcohol or smoking.
There are several studies conducted more recently from outside the US. A
Norwegian record-linkage study of 143,842 subjects was conducted on all inhabitants of
Oslo aged 51-90 years in 1992, and followed-up until 1998 (Naess, Nafstad, Aamodt,
Claussen, & Rosland, 2007). Hazard ratios (HR) were calculated based on quartiles of
long-term PM2.5 and PM10 exposure, stratified by gender and age at enrollment (51-70
and 71-90 years). The crude HRs for cardiovascular (CVD) mortality for a quartile
increase ofPM2.5were 1.11 (95% Cl, 1.06-1.16) in 51-70 year old men, 1.06 (95% Cl,
1.03-1.09) in 71-90 year old men, 1.16 (95% Cl, 1.09-1.24) in 51-70 year old women,
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and 1.02 (95% Cl, 1.00-1.05) in 71-90 year old women. The corresponding crude HRs
for COPD mortality were 1.32 (95% Cl, 1.17-1.49), 1.14 (95% Cl, 1.04-1.24), 1.18 (95%
Cl, 1.03-1.34), and 1.09 (95% Cl, 1.00-1.18). The HRs for PM2.5 exposure almost did not
change after adjusting for occupation and education. The same results were obtained with
PM10 exposure. The overall (gender combined) risk of death associated with a quartile
increment of PM2.5 was (RR= 1.11 (95% Cl, 1.07-1.15) for CVD and RR = 1.17( 95%
Cl, 1.09-1.25) for COPD (Naess et ah, 2007).
Although this was a large study with good data on mortality and air pollution
estimates, an important limitation was that it did not have information on smoking and
other lifestyle factors. Thus, we do not know the contribution of these factors on the
effect estimates.
Hoek et al. investigated a random sample of 5000 people; 489 of 4492 of the final
sample who completed the questionnaire (11%) died during 1986-1994 in the
Netherlands and observed that cardiopulmonary mortality was associated with living near
a major road with a relative risk of 1.95 (95% Cl: 1.09-3.52). Of these subjects, 2174
were males (48.4%) and about 62 years old (Hoek, Brunekreef, Goldbohm, Fischer, &
van den Brandt, 2002). Another cohort study conducted by Filleul et al. in France found
that urban air pollution was associated with increased mortality over 25 years of follow
up ecological study in France (Filleul et ah, 2005). This study had 14284 participants,
6802 males and 7482 females with a total mean age of 42.2. Cardiopulmonary mortality
was higher for men than for women, and strongly associated with smoking habits.
Mortality was also associated with NO2 with a RR of 1.27 (95% Cl: 1.04 to 1.56) for
each 10 mg/m increase in NO2 levels. In a 30 year follow cohort study by Frostad et ah

36

of 17678 Norwegian participants, respiratory symptoms were reported by 8950 persons
(51%): 4311 men and 4639 women. The researchers showed that respiratory symptoms
significantly predicted mortality from all causes (Frostad, Soyseth, Andersen, & Gulsvik,
2006). They also studied the relationship between 11 respiratory symptoms and total
mortality for males and females separately. The relative mortality risk in comparison with
asymptomatic subjects varied from 1.36 (95% Cl 1.25-1.48) for cough symptoms to 2.46
(2.13-2.85) for severe dyspnea amongst males. Among females, the relative risks were
1.28 (1.16-1.40) and 1.52 (1.31-1.75), respectively, for cough symptoms and severe
dyspnea. The relative risk of mortality in individuals with 1-3, 4-6 and 7 or more
symptoms was 1.20, 1.60 and 2.53 in males and 1.14, 1.47 and 1.84 in females.
Lastly, the Swiss study on Air Pollution and Lung Disease in adults (SAPLADIA)
study, which was conducted in Switzerland as a prospective study of 9651 adults (18 to
60 years of age) randomly selected from population registries in 1990; participants were
assessed in 1991, and 8047 participants reassessed in 2002. In the intervening years,
reported improvements in air quality and a drop of 10 pg/m3 PMio over 11 years of
follow up were associated with reduced FEV1 by 9% and of FEF25-75 by 16%. (Downs
et ah, 2007).
J. Possible Biological Mechanisms
1. Human Studies
a. PMio and COPD The biological mechanism behind the association
between ambient PM levels and incidence of chronic respiratory disease are not fully
understood. In vitro studies have shown that PMio causes several toxicological effects on
the cellular level, such as cytotoxicity, mutagenicity, DNA damage, and stimulation of
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cytokine production (Donaldson & MacNee, 2001; Sanchez-Perez et al., 2009). This
happen as a result of DNA double-strand breaks (DSBs) (Sanchez-Perez et ah, 2009).
The histone H2A.X undergoes phosphorylation at Seri39 to form cH2A.X, and is
mediated by phosphoinositide 3-kinase-related protein kinases (PIKKs), including ataxia
telangiectasia mutated (ATM), ATM and Rad-3 related kinase (ATR), and DNA
dependent protein kinase (DNA-PKcs). ATM and ATR activate the checkpoint kinases,
Chkl and Chk2, and tumor suppressor 53-binding protein 1 (53BP1). 53BP1 binds to the
DNA-binding domain of p53, enhances p53-mediated transcriptional activation, and
rapidly co-localizes with cH2A.X in response to DNA damage. After that, p53 initiates
different transcriptional programs that lead to cell cycle arrest, cellular senescence, or
apoptosis through the ATM/ATR and Chkl/Chk2 kinases. The cell undergoes cell cycle
arrest to provide time to carry out DNA repair or apoptosis, which includes the formation
of DNA double-strand breaks, cH2A.X generation, and 53BP1 recruitment. This
increases all-cause mortality overall and lung cancer specifically (Sanchez-Perez et ah,
2009). This study conducted in Mexico on cells derived from human adenocarcinoma
was obtained from the American Type Culture Collection; they then used the comet
assay, Western blot, immunofluorescence labeling, and cell apoptosis assay.
Other potential mechanisms for promotion of COPD may be include impairment of tissue
repair (Donaldson, Stone, Clouter, Renwick, & MacNee, 2001). Donaldson et ah
explained in his review that macrophages play an important role in phagocytosis of
particulate matter. It seems that the adverse effects of these particles may be mediated in
part by their ability to inhibit phagocytosis and failure of macrophage clearance
(Donaldson et ah, 2001; Renwick, Donaldson, & Clouter, 2001). The decreased
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phagocytosis could allow enhanced interaction between particles and the epithelium,
which occurs in any case because of the sheer number of particles. This leads to proinflammatory cytokine production by macrophages due to oxidative stress from the
surface of the particles and chemokine production by the epithelium (Donaldson et ah,
2001)
It has been reported in several reviews that air pollutants could prolong mucous
clearance and impair alveolar function (Fishman, 2008; Renwick et ah, 2001;
Sharafkhaneh, Hanania, & Kim, 2008; Taraseviciene-Stewart & Voelkel, 2008).
Particulate matter may also a calcium change in macrophages and epithelial cells that
could be important in priming and activating cells for inflammation (Barlow, Shukla,
Mossman, & Lounsbury, 2006). In the Barlow’s study, it was conducted on cell cultures
obtained from non-transformed murine alveolar type II epithelial cell lines from the
Department of Pharmacology, University of Vermont, US.
b. PM2.5and COPD PMio includes sulfates, nitrates, acids, metals, and
particles with various chemicals adsorbed onto their surfaces as well. Since PM2.5
particles are a subset of PM10 and thus much smaller, they may cross various membranes
more easily, carrying with them chemicals which may, in turn, have various toxic or
chemical effects. For this reason, PM2.5 may play the largest role in affecting human
health because they may be more toxic. (Pope & Dockery, 2006). Because of its smaller
size, PM2.5 can be inhaled more deeply into the lungs, remains suspended for longer
periods of time, penetrates more readily into indoor environments which adds to the
outdoor exposure, and is transported over much longer distances (Pope & Dockery,
2006). One of the common mechanisms for PM2.5 includes pulmonary and systemic
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oxidative stress, inflammation, atherosclerosis, and related cardiovascular disease (Pope
& Dockery, 2006). This mechanism starts with inflammation of the endothelium, which
leads to easier passage of lipids across the arterial wall, and initiation and progression of
atherosclerosis. It is induced by long-term chronic PM2.5 exposure. Short-term elevated
PM exposures and related inflammation may also contribute to acute thrombotic
complications of atherosclerosis, possibly increasing the risk of atherosclerotic plaques to
rupture and clotting, thus precipitating acute cardiovascular or cerebrovascular events
(MI or ischemic stroke) as mentioned in the review by Pope & Dockery in 2006.
Systemic inflammation associated with COPD may contribute to cardiovascular risk by
“provokeing alveolar inflammation, with release of mediators capable, in susceptible
individuals, of causing exacerbations of lung disease and of increasing blood
coagulability, thus also explaining the observed increases in cardiovascular deaths
associated with urban pollution episodes.” (Pope & Dockery, 2006).
c. Ozone and COPD What we know about O3 potential effects on humans
comes mostly from animal models (Foronjy et al., 2006; Foronjy, Okada, Cole, &
D'Armiento, 2003; Hautamaki, Kobayashi, Senior, & Shapiro, 1997; Zhong, Zhou, load,
& Pinkerton, 2006). O3 affects the human body through free radicals that are formed in
the reaction between O3 and polyunsaturated fatty acids, sulfhydryl amino acids, and
some electron rich compounds (Goheen, O'Rourke, & Larkin, 1986; Kanofsky & Sima,
2000; Leon et al., 1998; Ueno, Hoshino, Miura, & Shinriki, 1998). Free radicals can lead
to cell damage mediated by other materials produced by O3 such as lipid hydroperoxide,
aldehydes, and hydrogen peroxide (L. Li, Hamilton, & Holian, 2000). It has been found
to cause pulmonary fibrosis and change in the epithelial layer due to its nature as oxidant
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gas pollutant. This study conducted on 8-9 week old male mice (approximately 20 g) (Li
et ah, 2000). The oxidative property of ozone was also found to injure the extracellular
matrix in several cell cultures of animal studies (G. M. Brown & Donaldson, 1988;
Slodkowska, 1991; Vlahovic, Russell, Mercer, & Crapo, 1999). The potential mechanism
may possibly include alterations of lung cytokines, degradation of lung connective tissue
by direct cleavage of free radicals or enzymatic proteolysis, and finally, oxidative stress (
Brown & Donaldson, 1988; de Torres et al., 2006; Houghton, Mouded, & Shapiro, 2008;
Slodkowska, 1991; Vlahovic et al., 1999).
Overall, exposure to particulate air pollution and O3 has been found in an
experiment on human cell cultures to activate nuclear factor-kappa B (NF-kB), a
transcription factor stimulated in response to many proinflammatory agents (Jimenez et
al., 2000). It has been reported in the same study of human cell cultures that this causes
nuclear translocation, DNA-binding, and transcriptional activation of NF-kB, even in the
absence of IkB degradation by an iron-mediated mechanism. IkBa allows NF-kB
translocation of the nucleus when it is phosphorylated by IkB kinase (IKK), resulting in
IkBa degradation (Jimenez et al., 2000).
d. Particulate Matter and yls/Zzma/Particulate matter (PM) can contribute
to asthma exacerbation and possibly disease prevalence (Li & Nel, 2006; Oberdorster,
2001). The exact mechanism is uncertain, but PM contains organic chemicals that are
capable of participating in redox cycling reactions that generate Reactive Oxygen Species
(ROS) and oxidative stress in the lung, which (Fahy et al., 2002; Li & Nel, 2006). which
interferes with antigen presenting cell capability such as dendritic cells (Kantengwa,
Jomot, Devenoges, & Nicod, 2003). It also leads to IgE production and allergic
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inflammation (Li & Nel, 2006). However, as previously discussed, this mechanism is
different for COPD patients.
Cells have developed a defense mechanism to overcome the effects of oxidative
stress generated by electrophilic and redox cycling chemicals (Li, Hao, Phalen, Hinds, &
Nel, 2003). This mechanism includes antioxidant enzymes that metabolize redox cycling
chemicals, eliminate excessive ROS, and protect cells against the damaging effects of
electrophiles and oxidants (Li et al., 2004; Li et al., 2003). If the function of these
protective enzymes decreases or is altered, it may expose individuals to PM-induced
disease processes such as asthma (Fryer et al., 2000; Mapp et al., 2002).
Particulate matter may also act as an irritant, stimulating sensory nerves in asthmatic
patients’ airways to cause cough, reflex bronchoconstriction, and increased mucus
secretion (Barnes, 1995).
e. Ozone and Asthma The mechanisms by which O3 increases airway
inflammation in asthmatic patients is not fully understood, but a study suggest that O3
may increase the expression of cytokines such as IL-6, IL-8, GM-CSF, and tumor
necrosis factor alpha (TNF-a) (Devalia et al., 1993). It may also involve oxidative
activation of the transcription factor nuclear factor KB (NF-KB) as mentioned earlier
(Schreck, Richer, & Baeuerle, 1991). As a consequence, it will induce cyclooxygenase
(COX-2) (Barnes, 1995), cytosolic phospholipase A, and various chemo attractant
cytokines (chemokines) such as IL-8, which attract neutrophils and RANTES (Released
from Activated Normal T cells, Expressed and Secreted), which in turn attract
eosinophils (Barnes, 1995).
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The release of IL-8 from airway epithelial cells in patients with asthma might
result in an eosinophilic inflammation, IL-8 becomes chemo attractant for eosinophils in
the presence of cytokines present in asthmatic airways, including IL-5 and GM-CSF
(Warringa et ah, 1992). Chronic exposure of epithelial cells may amplify eosinophilic
inflammation and inhaled allergens in asthmatic airways, thus increasing asthma
symptoms and enhanced bronchoconstriction responses.
2. Animal Studies
Animal experiments in vivo and in vitro have found pro-inflammatory
effects for PMio, including oxidative stress, up regulation of transcription factors, and
pro-inflammatory gene expression (MacNee & Donaldson, 2003). One of the possible
mechanisms is the generation of inflammation through redox transcription factors in
COPD, an oxidative factor which is generated directly from ultrafine and transition metal
components of PMio and indirectly from recruitment to airspaces and activation of blood
leukocytes (MacNee & Donaldson, 2003; MacNee & Rahman, 2001).
Li et ah, (1995) developed a rat model to study the mechanisms of the epithelial
permeability to 125 iodine-labeled bovine serum albumin (125I-BSA) (Li, Donaldson,
Brown, & MacNee, 1995). It has been reported that the increase in epithelial permeability
induced by intratracheal instillation of heat-killed Corynebacterium parvum produced a
peak influx of neutrophils into the bronchoalveolar space at 16 h, which occurred after
the peak increase in epithelial permeability (8 h). The increased epithelial permeability
induced by C. parvum did not appear to be protease- or oxidant-mediated. Depletion of
peripheral blood neutrophils was achieved by an intravenous injection of anti-neutrophil
polyclonal antibody. Bronchoalveolar lavage (B AL) of leukocytes from rats at 8 h, but
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not 16 h, after treatment with C. parvum caused a modest increase in epithelial
permeability when re-instilled intratracheally into control rat lungs ( Li et ah, 1995). The
presence of dramatically increased levels of tumor necrosis factor (TNF) in BAL 8 h in
contrast to a slight increase in BAL 16 h after C. parvum, the release of TNF from 8 h
macrophages, the increased epithelial permeability induced by TNF in epithelial
monolayers in vitro, and the inhibition of C. parvum-induced epithelial permeability by
TNF antibody support the premise that TNF is a major player in the increased epithelial
permeability that occurs during C. parvum-induced acute alveolitis (Li et ah, 1995).
An animal-model study conducted at UCLA found that acute exposure to PM2.5
from vehicle emissions could trigger plaque deposits in arteries - the established risk
indicator of heart attacks and stroke. In this study, researchers exposed mice with high
cholesterol to either PM2.5 or PM10 pollutant particles from downtown Los Angeles
freeway emissions and compared them to mice exposed to filtered air with no particles
for five weeks. The result was that mice exposed to PM2.5 had a 55% greater
atherosclerotic plaque development than mice breathing filtered air. Additionally, mice
breathing PM2.5 had 25% greater atherosclerotic plaque development than mice breathing
PM10 particles. These results suggest that the smaller particles were more likely to lead to
cardiovascular disease (Araujo et ah, 2008).
A study conducted at NYU revealed that chronic exposure to air pollution can
contribute to an increased risk of heart disease in mice. In this study, two groups of mice,
genetically prone to developing cardiovascular disease, were fed either a normal or highfat diet. For six months, half of the mice in each group inhaled significant doses of either
filtered air without particles or air with PM2.5 concentrated at 15.2 pg/m , a dose similar
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to the air pollution in New York City. Results showed that mice breathing polluted air
had more plaque in their arteries than mice breathing filtered air. Additionally, exposure
to PM2.5 air increased cholesterol levels in both the normal and the high-fat diet mice.
High levels of cholesterol in the blood have been shown in many other studies to
contribute to atherosclerosis, which corresponds with an increased risk of heart attacks
and strokes (Brown, Rushton, Mugglestone, & Meechan, 2003; Ravnskov, 2002; Roberts
& Martin, 2008; Roberts, 2008). Therefore, the results demonstrate a clear cause and
effect relationship between exposure to air pollution and atherosclerosis (Sun et al.,
2005).
Overall, in a study titled, “Animal models of chronic obstructive pulmonary
disease,” Wright et al. found none of the models reproduced the exact changes seen in
humans (Wright, Cosio, & Churg, 2008), but cigarette smoke-induced disease appears to
come closest. Studies of genetically modified animals also, in some instances, shed light
on processes that appear to play a role (Wright et al., 2008). In the cigarette smoke model,
it produces small airway remodeling in laboratory animals, possibly by direct induction
of fibrogenic growth factors in the airway wall, and also produces pulmonary
hypertension, at least in part through direct up regulation of vasoactive mediators in the
intrapulmonary arteries (Churg, Cosio, & Wright, 2008). Smoke exposure causes goblet
cell metaplasia and excess mucus production in the small airways and proximal trachea,
but these changes are not good models of either chronic bronchitis or acute exacerbations
(Churg et al., 2008).
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Abstract
Background and Objective: Studies show different results concerning the association
between ambient particulate matter (PM) air pollution and outcomes among persons with
chronic obstructive pulmonary disease (COPD). These variations could be due to the
challenges in estimating accurate ambient air pollution levels for each subject. The
AHSMOG-1 study (N=6,338) has previously found males had an elevated risk of death
associated with ambient PMio for any mention of non-malignant respiratory disease. The
aim of this study is to assess the effect of chronic exposure to ambient air pollutants
(PM2.5 and O3) and risk of non-cancer respiratory mortality among a new and larger
cohort of Adventists (the Adventist Health and Smog Study 2 [AHSMOG-2]) who have
never smoked and who have not changed their primary residence since enrollment in the
study. Subjects were recruited between 2002 and 2007 and mortality follow-up is through
2009.
Methods: Using data from the Adventist Health Study-2, a cohort of 97,000 US subjects,
a subgroup of 43,964 never smoking subjects was selected who had not moved since
enrollment into the parent study. Subjects were enrolled in the parent study from all 50
states between 2002 and 2007 and completed a 50 page baseline questionnaire which
included demographics, medical history, time spent outdoors, exercise, smoking, and
diet. During an average follow-up of 3 years and 10 months through 2007, a total of 235
subjects died with a diagnosis of non-cancer respiratory disease. The Cox proportional
hazard model was used for survival analysis, adjusting for a number of potential
confounders including age, race, education, body mass index (BMI), physical exercise,
and dietary patterns. Inverse distance weighting (IDW) with interpolation to residence
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address was used to estimate individual ambient air pollution level. Cumulative monthly
averages from 12 months prior to enrollment until one month before censoring were used.
Results and Conclusion: For each 10 ppb increase in O3, the hazard ratio (HR) for any
cause of death due to non-cancer respiratory diseases was 1.93 (95% (Cl): 1.31- 2.85) in
the single-pollutant model and 1.95 (95 % Cl: 1.32-2.87) in the two-pollutant model with
PM2.5. No associations were found with PM2.5 either in single or two-pollutant models
(HRs and 95 % Cl were 1.12 (0.64-1.97) and 1.21 (0.69-2.12) respectively). These
findings could have implications for policy regulations.

Keywords: air pollution, non-cancer respiratory mortality, long-term exposure,
particulate matter, ozone
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Introduction
Chronic obstructive pulmonary disease (COPD) incidence and mortality are
increasing worldwide. It has been estimated that COPD will be the third leading cause of
tli

death in 2020, an increase from being the 6 leading cause in 1990 (Martin et ah, 2008;
Raherison & Girodet, 2009). Several factors have been postulated as playing a role in this
increase such as ambient particulate matter (PM) air pollution. Many large
epidemiological studies such as the Six Cities Study (Dockery et al., 1993), the American
Cancer Society (ACS) study (Pope et al., 2002), and the Adventist Health and Smog
(AHSMOG) study (Abbey et al., 1999), have demonstrated an association between
ambient particulate matter (PM) air pollution and all-cause mortality or cardiopulmonary
mortality. In the Harvard Six Cities Study, cardiopulmonary mortality was significantly
associated with mean sulfate and fine particulates over the study period (Dockery et al.,
1993). However, no results have been reported specifically for non-cancer respiratory
mortality. In addition, air pollution exposure was represented by one average value for
each city so that only six air pollutant data points were used to estimate the exposure
(Higgins et al., 2003).
The American Cancer Society Study (ACS) also known as the Cancer Prevention
Study II (CPS-II)found that fine particulates and sulfur oxide-related pollution were
associated with all cause as well as lung cancer and cardiopulmonary mortality (Pope et
al., 2002; Pope et al., 1995). Furthermore, it was suggested that long-term exposure to
combustion-related fine particulate air pollution is also an important environmental risk
factor for cardiopulmonary and lung cancer mortality, but no results are given
specifically for the risk of non-cancer respiratory mortality in this study. A limitation was
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that the approach to subject select selection were enrolled by volunteers from among their
friends and relatives, so it is likely that the subjects probably were not representative of
the general population within each city (Higgins et al., 2003).
The AHSMOG-1 (Abbey et al., 1999) confirmed the results of the previous studies
(Harvard Six Cities & ACS) and also found associations between ambient air pollution
and non-cancer respiratory mortality using the inverse distance weighted (IDW)
interpolations from the three nearest fixed monitoring stations to residence and workplace
zip codes. Ambient PMio was associated with any mention of non-malignant respiratory
disease mortality with RR-1.18 (95% [Cl]: 1.02, 1.36) (Abbey et al., 1999), and with
lung cancer mortality in both sexes, but with a more marked effect in males than females
(Beeson, Abbey, & Knutsen, 1998).
Although several epidemiologic studies suggest a link between air pollutants and
adverse COPD outcomes (Abbey et al., 1999; Dockery et al., 1993; Naess, Nafstad,
Aamodt, Claussen, & Rosland, 2007; Pope et al., 2002), it is not clear whether long-term
ambient air pollution exposures, particulate or gaseous, contribute to increased risk of
non-cancer respiratory deaths among never smokers.
The purpose of this study was to assess the effect of chronic exposure to ambient air
pollutants and the risk of non-cancer respiratory mortality among never smoking subjects
who have not changed their primary residence since enrollment in the study.
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Materials and Methods
Study population
The Adventist Health and Smog-2 study (AHSMOG-2) began in 2002 as a sub
study of the Adventist Health Study-2, a cohort study of about 97,000 subjects from all
50 United States and 5 Canadian provinces (Butler et ah, 2008). Among subjects living in
the US, 48,399 had not changed their residence since enrollment and had never smoked.
We also excluded those who died due to lung cancer, and people who had lived less than
1 year at their residence at time of enrollment. Thus our analytic population for this
study consists of 43,964 never-smoking subjects residing in the U.S.
As part of their enrollment into the AHS-2, all subjects completed a comprehensive 50
page questionnaire that included questions on demographics, medical history, education,
anthropometric data, smoking history, dietary habits, exercise patterns, and time spent
outdoors.
Estimation of ambient air pollution concentrations
PM2.5 and O3 monthly concentration averages (January 1, 2000 to December 31,
2007) were estimated using information from the Aerometric Information Retrieval
Systems (AIRS) database maintained by the U.S. Environmental Protection Agency
(EPA). For each subject, cumulative exposure was calculated from 12 months prior to
enrollment until one month before censoring. Inverse distance weighting (IDW) was used
to estimate ambient air pollution levels. IDW is a deterministic interpolation method that
assumes that concentrations from stations closer to the location of interest are more
influential in the estimation than concentrations from more distant stations (Watson,
1992). Monitoring sites are weighed by the inverse of their distance from the estimation
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point. The weighted concentrations are divided by the sum of the weights so that the
weights sum to one. As number of monitoring station increases, nearby stations obtain
greater dominance over more distant stations (Frank & Horie, 1977). Monthly
concentrations were interpolated to the geographic of residential and work/ zip codes
Ascertainment of deaths
Fatal non-cancer respiratory mortality (emphysema, bronchitis, asthma and
pneumonia), defined by codes J10-J18 and J40-J47 of the International Classification of
Diseases, 10th Revision (ICD-10) (CDC, 2010) as any mention of non-cancer respiratory
disease on the death certificate was used in this study.
Deaths were ascertained through 2007 using record linkage between the AHS-2
database and the National Death Index (Centers for Disease Control and Prevention,
National Center for Health Statistics, Atlanta, GA, USA). Based on these criteria, a total
of 256 non-cancer respiratory deaths were identified among our analytic population.
Statistical analysis
We compared the baseline descriptive information between non-cancer
respiratory mortality cases and no cases using the student t-test or Chi-square test. Timedependent Cox proportional-hazards regression modeling was used to study associations
between pollutants (PM2.5, and ozone) and non-cancer respiratory mortality with attained
age as the time variable (Greenland, 1989). A basic multivariable model was developed
which included gender, education, and calendar time. In addition to the main exposure,
we added interaction terms between several variables such as gender, race, vegetarian
dietary status, and education to evaluate effect modification, but none were significant
and thus not included in the final model. All candidate variables including Body Mass
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Index (BMI), time spent outdoors, gender, education, alcohol, race, vegetarian dietary
status, exercise, and co-morbidities were entered into the basic multivariable model one
at a time to assess their impact on the main effect. Only time spent outdoors changed the
hazard ratio (HR) > 10% and was retained in the final model.
The final model estimated the hazard ratio (HR) and 95% confidence intervals for
non-cancer respiratory mortality outcomes in relation to ambient air pollutant exposures
modeled as continuous variables after adjusting for selected risk factors (gender,
education, and time spent outdoors) within both single and two-pollutant models.
'j

Hazard ratios were calculated for an increment of 10 pg/m for PM2.5 and 10 ppb for O3.
To standardize the exposure window preceding events, we therefore used the following
method 1) selected a 3-year average as our moving time period of exposure, but excluded
the last month before the event to avoid measuring short-term effects. We decided to use
this range because we had first death cases after 3 years; 2) we calculated the exposure
through accumulative average 12 months prior to enrollment until one month before
censoring. Participants who did not die were censored at end of follow-up or at time of
last contact if they were lost to follow-up.
The proportional hazards assumption was checked by examining log
[-log(survival)] curves versus the time variable (attained age) as well as the product term
of each respective variable in the final model with the log of the time variable
(Greenland, 1989). Each of these interaction terms produced a />-value > 0.05 based on
the Wald statistic, indicating that the proportional hazards assumptions were not seriously
violated. This was supported further by visual inspection. The SAS statistical package
(version 9.2; SAS institute, Cary, NC) was used for all analyses.
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Results
Over 3 year and 10 month of follow-up period (2002-2007), 235 non-cancer
respiratory deaths were recorded. Those who died were older at baseline, spent less time
outdoors, had fewer years of education, lower levels of physical exercise, were more
likely to have one or more comorbidities, and were more likely to be male (Table 3-1).
Frequency histograms of the individual mean ambient concentrations of each of the PM
and ozone fractions from 2000 to the censoring month are given in Figures 3-1 and 3-2.
Table 3-2 gives an overview and frequency of the various diagnoses included among the
non-cancer respirator mortality outcomes.
Associations with ozone
A significant relationship was found between ozone and non-cancer respiratory
mortality HR=1.93 [95 (Cl), 1.31-2.85] for each increment of 10 ppb (Table 3-3). The
estimates remained virtually unchanged in the two-pollutant model with PM2.5 (HR=1.95
[95% Cl, 1.32-2.87]).
Associations with PM? s
No significant association was found between ambient PM2.5 and non-cancer
respiratory mortality in single-pollutant models (HR=1.12 [95% Cl, 0.64-1.97] for each
increment of 10 pg/m3 (Table 3-3). In the two-pollutant model with O3 did not change
this relationship (HR = 1.21; 95% Cl, 0.69-2.12) (Table 3-3), but it has a greater effect.
Using cumulative monthly averages from the year 2000 to censoring or the timeindependent Cox model versus the 3-year moving average gave similar results but the
point estimate was somewhat stronger (Table 3-4).
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Discussion
Significant relationships were found between ozone and non-cancer respiratory
mortality. By limiting our study population to never smokers, we avoided the effect of
active smoking in our study. To our knowledge, no other cohort study on the health
effects of ambient air pollution on health has reported findings among never smokers
with stable residential histories throughout follow-up; therefore, we cannot readily
compare our findings with others.
Several studies have found an association between ambient particulate air
pollution - particularly PM2.5 and cardiopulmonary disease — and total mortality
(Halonen et al., 2010; Naess et ah, 2007; Pope et ah, 2002; Pope et ah, 2004; Samet,
Dominici, Curriero, Coursac, & Zeger, 2000). The Six Cities (Dockery et al., 1993) and
the ACS (Pope et al., 2002; Pope et al., 2004) studies reported a positive association
between cardiopulmonary disease (CPD) and cardiovascular deaths and long-term
exposure to ambient PM. The association was strongest for fine particles, with RRs
varying between 1.06 for CPD deaths (Pope et al., 2002) and 1.12 for cardiovascular
'j

deaths (Pope et al., 2004) for each increment of 10 pg/m after adjusting for age, sex, and
other demographic covariates. When comparing most-polluted with least-polluted areas,
the RR for CPD death was 1.31 for a difference of 24.5 pg/m3 in the ACS study (Pope et
al., 1995) and 1.37 for a difference of 18.6 pg/m3 in the Six Cities Study (Dockery et al.,
1993). The effect of fine particles on CPD mortality has not been reported before from
the AHSMOG-1. However, though no significant relationships were found for the
association between PM10 and CPD mortality, effect was higher for males s than females
(Abbey et al., 1999).
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In Europe, a study from Helsinki, Finland, was conducted to determine the short
term associations of Oswith cause-specific cardiorespiratory mortality and morbidity by
age groups (Halonen et ah, 2010). Daily levels of O3 were measured from 1998 to 2004.
All models were adjusted for PM2.5 and Poisson regression was used for the analyses. A
positive association was found between O3 and admissions for asthma

COPD in

elderly people (9.6%; 95% Cl 2.0%- 17.8% at 0-day lag for 25 mg/m3 increase in O3).
None of the respiratory outcomes, all respiratory disease mortality (J00-J99), pneumonia
(J12-J15, J16.8, J18), or pooled asthma-COPD (J41, J44-J46) showed any associations
with O3. A Norwegian record-linkage study of 143,842 Oslo residents aged 51-90 years
in 1992 was conducted and subjects followed until 1998 (Naess et al., 2007). Hazard
ratios (HR) were calculated based on quartiles of long-term PM2.5 and PM10 exposure,
and stratified by gender and age at enrollment (51-70 and 71-90 years). The crude HRs
for COPD mortality for a interquartile increase (6.56-11.45, 11.46-14.25, 14.26-18.43, or
18.44-22.34 pg/m3 ) of PM2.5 were 1.32 (95% Cl, 1.17-1.49) in 51-70 year old men, 1.14
(95% Cl, 1.04-1.24) in 71-90 year old men, 1.18 (95% Cl, 1.03-1.34) in 51-70 year old
women, and 1.09 (95% Cl, 1.00-1.18) in 71-90 year old women. The HRs for PM2.5
exposure did not change appreciably after adjusting for occupation and education, as well
as PM10 exposure. The overall risk of death associated with PM2.5 exposure was elevated
both for cardiovascular diseases (RR = 1.11, 95% Cl, 1.07-1.15 for a quartile increase)
and for COPD (RR = 1.17, 95% Cl, 1.09-1.25) (Naess et al., 2007). Although the
researchers evaluated the effect of smoking as a confounder using different methods, they
were unable to fully understand its effect because the original data did not include
information about smoking. (Naess et al., 2007).
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In addition, in this investigation we found that only O3 was associated with nonrespiratory mortality while PM2.5 showed only non-significant. This suggests different
biological behavior for the two pollutants. Our risk estimates are also higher than those
reported previously by others. There could be several possible explanations for this: our
study could have more precise estimates of ambient air pollution and thus less exposure
misclassification; Also, our population is more homogeneous with fewer additional risk
factors for respiratory disease. Subjects did not moved since enrollment into the study
and they are all never smokers, effectively eliminating confounding effects of smoking,
one of the strongest risk factors for COPD.
The U.S.EPA has suggested that the association observed with PM could instead
be due to gaseous pollutants (U.S. EPA., 1989), because components of air pollution
frequently occur together and are highly correlated. In our study the correlation between
concentration of PM2.5 and O3 was about 21. We found no significant association between
fatal non- cancer respiratory morality and fine particle (PM2.5) in single- or two-pollutant
models. However, in two-pollutant models, O3 strengthened the relationship between
PM2.5 and fatal non-cancer respiratory mortality, although the risk estimates were not
significant and only moderately slightly elevated. The modifying effect of O3 can
possibly be explained by other researchers’ findings which indicate that lung epithelial
permeability increases with exposure to O3 (Blomberg et ah, 2003), thus making the body
more susceptible to intrusion of particulate matter.
Possible biological mechanism:
PM2.5 may play the largest role in affecting human health because smaller
particle and may be more toxic than O3 (Pope & Dockery, 2006). They can be breathed
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more deeply into the lungs, remain suspended for longer periods of time, penetrate more
readily into indoor environments, and is transported over much longer distances (Pope &
Dockery, 2006). One of the common effects for PM2.5 includes pulmonary and systemic
oxidative stress, inflammation, atherosclerosis, and related cardiovascular disease (Pope
& Dockery, 2006). These mechanisms can be related to respiratory diseases by different
ways. Inflammation can be induced by long-term chronic PM2.5 exposure, which may be
exaggerated in case of pulmonary diseases because airway inflammation in asthma is
characterized by an eosinophilic inflammation, while in COPD it is characterized by
neutrophils (Barnes, 2000). Short-term elevated PM exposures and related inflammation
may also contribute to acute thrombotic complications of atherosclerosis, increasing the
risk of atherosclerotic plaques becoming more vulnerable to rupture and clotting, and
precipitating acute cardiovascular or cerebrovascular events (MI or ischemic stroke). This
may increase the risk of mortality among non-cancer respiratory cases because it has
been reported cardiovascular disease CVD is more frequent in COPD patients than in the
general population and may represent a burden greater than that of lung disease itself
(Huiart, Ernst, & Suissa, 2005). At the same time, systemic inflammation associated with
COPD may contribute to cardiovascular risk by “provoking alveolar inflammation, with
release of mediators capable, in susceptible individuals, of causing exacerbations of lung
disease and of increasing blood coagulability, thus also explaining the observed increases
in cardiovascular deaths associated with urban pollution episodes” (Pope & Dockery,
2006).
The observed negative effects of ambient O3 on respiratory health are in line with
results from animal models (Foronjy et ah, 2006; Foronjy, Okada, Cole, & D'Armiento,
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2003; Zhong, Zhou, load, & Pinkerton, 2006). These animal models found in vivo and in
vitro pro-inflammatory effects for O3 including oxidative stress, up regulation of
transcription factors and pro-inflammatory gene expression. In addition, generation of
inflammation through redox transcription factors in COPD is the oxidative factor which
is generated directly from ultrafine and transitional metal components of O3 and
indirectly from the recruitment to the airspaces and activation of blood leukocytes
(MacNee & Donaldson, 2003; MacNee & Rahman, 2001).
One of the mechanisms by which O3 affects the human respiratory tract is
believed to be through the formation of free radicals that occur as a reaction between O3
and polyunsaturated fatty acids, sulfhydryl amino acids, and some electron rich
compounds (Kanofsky & Sima, 2000; Leon et ah, 1998). Free radicals can lead to cell
damage through other substances react with O3 such as lipid hydroxyperoxide, aldehydes,
and hydrogen peroxide (Li, Hamilton, & Holian, 2000). Ozone has been found to cause
pulmonary fibrosis and changes in the epithelial layer owing to its strong oxidative
capacity (Li et ah, 2000), and its oxidative properties can also cause injury to the
extracellular matrix (Slodkowska, 1991; Vlahovic, Russell, Mercer, & Crapo, 1999). The
potential mechanism may possibly include alterations of lung cytokines, degradation of
lung connective tissue by direct cleavage of free radicals or enzymatic proteolysis, and
finally, oxidative stress (de Torres, Campo, Casanova, Aguirre-Jaime, & Zulueta, 2006;
Houghton, Mouded, & Shapiro, 2008; Slodkowska, 1991; Vlahovic et ah, 1999). It has
been reported that O3 can increase airway inflammation and airway responsiveness, and
also can potentiate the airway response to inhaled allergens (Bernstein et ah, 2004).
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Strengths and limitations
Because all subjects in this subgroup are never smokers, our results are free from
the confounding effects of both past and current cigarette smoking and because of the
culture, also very little exposure to environmental or passive tobacco smoke. The
AHSMOG study has extensive information on lifestyle. We were thus able to adjust for
the effects of a number of factors found to be associated with non-cancer respiratory
mortality in this cohort such as gender, education, and time spent outdoors. This
adjustment actually strengthened the association between ozone and non-cancer
respiratory mortality.
Although we have found a relatively strong effect of ambient ozone on risk of
non-cancer respiratory mortality in this study, there are unknown amounts of
measurement error in both the estimated long-term ambient concentrations of pollutants
and other covariates. A potential source of measurement error is the exposure estimate
derived from interpolating ambient concentrations (PM2.5, O3) and measurement at fixed
monitoring stations (Abbey, Hwang, Burchette, Vancuren, & Mills, 1995).
Conclusions
In summary, ambient levels of ozone were found to increase the risk of death due
to non-cancer respiratory mortality among never smokers. The relationship with PM2.5
was stronger than has previously been found by other researchers and may be due to the
fact that this was a population of never-smokers. Further studies are needed among other
never smoking populations. If corroborated by other studies, our findings could have
implications for legislation.
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Table 3-1: Selected characteristics of study population at baseline
Variable

Age (Years)
BMI
Time Spent Outdoors (hours)
PM2.5(|ig/m3)

Ozone (ppb)
Gender

Total
(N=44199)
Mean (SD)
57.95(13.96)
26.95(5.76)
9.34(6.23)
11.73(2.33)
29.38(3.02)
N(%)
30101(68.1)
14098(31.9)
9818(22.5)
14618(33.4)
19260(44.1)
41259(93.4)

Cases*
(N=235)
Mean (SD)
78.62(11.99)
25.56(5.84)
9.25(6.14)
11.70(2.34)
29.42(3.04)
N(%)
119 (50.6)
116(49.4)
86(37.1)
71(30.6)
75(32.3)
229(97.5)

Non cases
(N=43964)
Mean (SD)
57.84(13.89)
26.96(5.76)
8.03 (6.72)
11.58(2.43)
30.67(3.64)
N(%)
29982(68.2)
13982(31.8)
9732(22.4)
14547(33.5)
19185(44.1)
41030(93.3)

p- value

<0.0001
0.0002
9.25 (6.14)
11.70(2.34)
29.41(3.03)

Females
<0.0001
Males
Education**
HS or less
<0.0001
SC+AD
BD+MD+DOC
Alcohol
No (last 12
0.0115
month)
2940(6.6)
Yes (last 12
6(2.5)
2934(6.7)
month)
Race
Non-Black
216(91.9)
32971(75.0)
33187(75.1)
<0.0001
Black
11012(24.9)
19(8.1)
10993(25.0)
Vegetarian
3386(7.7)
Vegan
21(8.9)
3365(7.7)
0.0864
Status
Lacto
14396(32.5)
94(40.0)
vegetarian
14302(32.5)
Pesco
4452(10.1)
22(9.4)
vegetarian
4430(10.1)
Semi
2390(5.4)
13(5.5)
vegetarian
2377(5.4)
None
19575(44.3)
85(36.1)
vegetarian
19490(44.3)
Exercise
Low
8558(19.4)
8437(19.2)
121(51.5)
<0.0001
Moderate
15326(34.9)
15387(34.8)
61(26.0)
High
20254(45.8)
20201(45.9)
53(22.5)
BMI
15-24.9
124(52.8)
18342(41.5)
18218(41.5)
0.0009
25-29.9
15373(35.0)
74(31.5)
15447(35.0)
30-59.9
37(15.7)
10379(23.5)
10342(23.5)
Co37570(85.0)
No
37423(85.1)
147(62.5)
<0.0001
morbidities§
Yes
6541(14.9)
88(37.5)
6629(15.0)
*cases are those who died due to non-cancer respiratory mortality.
**HS (high school), SC (some college), AD (associate degree), BD (bachelor degree), MD
(master degree) and DOC (doctoral degree).
§Angina, Myocardial infarction, congestive heart failure, stroke, transient ischemic attacks,
diabetes mellitus (I or II) and hypertension.
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Table 3-2: Frequencies of causes of death included among non-cancer respiratory
mortality
Disease 1

Disease 2

Disease 3

N

Pneumonia
Respiratory failure

89
45

COPD/Asthma
Other respiratory disorders

22
14

Other interstitial pulmonary diseases

9

Adult respiratory distress syndrome
Pulmonary edema
Pleural effusion

6
5
2
1

Hypersensitivity pneumonitis due to organic dust
Post procedural
respiratory
disorders
Respiratoryfailure
Pneumonia
Respiratoryfailure
COPD/Asthma
Other chronic obstructive pulmonary
Pneumonia
disease
Respiratory failure
Other interstitial pulmonary diseases
Respiratory failure
Pulmonary edema
Pneumonia
Other interstitial pulmonary diseases
Pneumonia
Abscess of lung and mediastinum
Respiratory failure
Other respiratory disorders
Pneumonia
Adult respiratory distress syndrome
Respiratory failure
Pneumonia
6 diseases:
Hypersensitivity
pneumonitis due to
organic dust
Respiratory failure
Adult respiratory
Other interstitial pulmonary
distress syndrome
diseases
effusion
Total

62

1
14
11
3

Emphysema

Pneumonia
Pleural

3
2
2
1
1
1
2

1

235

Table 3-3: Hazard ratio of non-cancer respiratory mortality according to increments of
long-term concentrations of PM2.5 and ozone (2000-2007): Single & two pollutant
models. (Air pollution estimate through cumulation since 12 months prior baseline)
Model
Single
pollutant

Variable

HR (95% Cl)

PM 2.5 (A10ng/m3)
Female
Male

Gender

1.12 (0.64-1.97)
1
3.33 (2.44-4.55)

Calendar time

1
0.80 (0.57-1.14)
0.60 (0.42-0.85)
0.95 (0.92-0.97)
1
0.61 (0.36-1.05)
1.23 (1.11-1.37)

Ozone (A10 ppb)
Gender

1.93 (1.31-2.85)
1

Education

HS or less
SC+AD
BD+MD+DOC

Time spent outdoors (hrs)
Race

Black
Non black

Single
pollutant
Female
Male

Education

HS or less
SC+AD
BD+MD+DOC

Time spent outdoors (hrs)
Race

Black
Non black

Calendar time

3.36 (2.46-4.58)

1
0.78 (0.55-1.11)
0.57 (0.40-0.82)
0.94 (0.92-0.97)
1
0.72 (0.42-1.23)
1.25 (1.13-1.39)

Two
pollutants
PM25(A10ng/m3)
Ozone(A10 ppb)
Gender

Female
Male

Education

HS or less
SC+AD
BD+MD+DOC

Time spent outdoors (hrs)
Race

Black
Non black

Calendar time
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1.21(0.69-2.12)
1.95 (1.32-2.87)
1
3.35 (2.46-4.58)

1
0.78 (0.55-1.11)
0.57 (0.40-0.81)
0.94 (0.92-0.97)
1
0.70 (0.41-1.21)
1.25 (1.13-1.40)

Table 3-4: Hazard ratio of non-cancer respiratory mortality according to increments of
long-term concentrations of PM2.5 and ozone (2000-2007): Single & two pollutant
models. (Air pollution estimate through moving average method from 36 months prior to
baseline)
Model

Variable

HR (95% Cl)

Single
pollutant
PIVh.s (A10ng/m3)
Female
Male

Gender

1.19 (0.7-2.04)
1
3.33 (2.44-4.55)

Calendar time

1
0.80 (0.57-1.14)
0.59 (0.42-0.85)
0.95 (0.92-0.97)
1
0.61 (0.35-1.04)
1.23 (1.11-1.37)

Ozone(A10 ppb)
Gender

2.04 (1.40-2.98)
1

Education

HS or less
SC+AD
BD+MD+DOC

Time spent outdoors (hrs)
Race

Black
Non black

Single
pollutant
Female
Male

Education

HS or less
SC+AD
BD+MD+DOC

Time spent outdoors (hrs)
Race

Black
Non black

Calendar time

3.37 (2.46-4.60)

1
0.78 (0.55-1.11)
0.57 (0.40-0.81)
0.94 (0.92-0.97)
1
0.73 (0.42-1.25)
1.25(1.12-1.39)

Two
pollutants
PM2.5(A10|jg/m3)
Ozone(A10 ppb)
Gender

Female
Male

Education

HS or less
SC+AD
BD+MD+DOC

Time spent outdoors (hrs)
Race

Black
Non black

Calendar time
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1.17 (0.66-2.09)
2.22 (1.49-3.32)
1
3.35 (2.45-4.56)

1
0.78 (0.55-1.10)
0.57 (0.40-0.80)
0.94 (0.92-0.97)
1
0.71 (0.41-1.20)
1.26(1.13-1.40)

Figure 3-1: Frequency distribution of mean ambient concentration of PM2.5 from 2000 to
censoring month
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Figure 3-2: Frequency distribution of mean ambient concentration of O3 from 2000 to
censoring month
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Abstract
Background and Objectives: Several studies show an association between ambient
particulate matter (PM) and all-cause mortality. The AHSMOG-1 study (N=6,338) has
previously found associations between ambient air pollution and incident COPD using an
inverse distance weighted (IDW) method from the three nearest fixed monitoring stations
to residence and workplace. However, few studies have assessed the risk of death among
disease specific subgroups such as those with chronic obstructive pulmonary disease
(COPD). The aim of this study was to assess the effect of chronic exposure to ambient air
pollutants on the risk of all-cause mortality among persons with COPD and/or asthma.
The study population consists of subjects who have never smoked and who have not
changed their primary residence since enrollment in the study. This study specifically
assessed chronic exposure to ambient particulate and gaseous pollutants (PM2.5 and O3)
by utilizing the Adventist Health and Smog Study 2 (AHSMOG-2) and mortality data
from the National Death Index (NDI) for the years 2002-2009.
Methods: Using data from the Adventist Health Study-2, a cohort of 97,000 US and
Canadian subjects, a subgroup of 3,666 subjects who never smoked, lived in the US, and
who reported having been diagnosed with either COPD and/or asthma was selected.
Further, these subjects had not moved since enrollment into the parent study and had
completed the 50 page baseline questionnaire which included demographics, medical
history, time spent outdoors, exercise, smoking, and diet. A total of 102 subjects have
died during an average of 3 years and 10 months of follow-up. The Cox proportional
hazard model was used for survival analysis, adjusting for a number of potential
confounders including age, race, education, body mass index (BMI), time spent outdoors,
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physical exercise, and dietary patterns. Inverse distance weighting (IDW) with
interpolation to residence address was used to estimate individual level ambient air
pollution. Cumulative monthly and averages from 12 months prior to enrollment until
one month before censoring were used.
Results and Conclusion: For each 10 pg/m3 increase in PM2.5, the hazard ratio (HR) for
all-cause mortality was 2.70 (95% (Cl): 1.09-6.65) in the single-pollutant model and 2.23
(95 % Cl: 0.99-5.03) in the two-pollutant model with O3. No significant associations
were found with Os, either in single or two-pollutant models (HRs and 95% Cl were 1.32
(0.74-2.36) and 1.33 (0.79-2.25) respectively). These findings could have implications for
policy regulations.
Keywords: air pollution, all-cause mortality, long-term exposure, particulate matter,
ozone, chronic obstructive pulmonary disease, asthma.
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Introduction
COPD was the underlying cause of death for 126,005 persons older than 25 in the
US in 2005 (MMWR, 2005, 2008), in 8% increase with respect to 2000(MMWR, 2005,
2008). From the 2000 to 2005 period, the COPD death rate for women increased by 23%,
although it was higher for men compared with women in each year (Celli, 2008; Lopez
et ah, 2006).
Asthma was lower. More than 4,000 deaths in the US were due to asthma each
year (11 deaths per day) (NCHS, 2001). It also acts as a “contributing factor” for an
additional 7,000 deaths each year (NCHS, 2001). Most of these deaths are avoidable with
proper treatment and care. Women and African Americans are at higher risk of asthma
mortality (NCHS, 2001; NIAID, 2001). The total mortality due to any cause of death
overall have increased more than 50% among all genders, age groups, and ethnic groups
since 1980 (NCHS, 2001).
Several factors have been postulated as playing a role in this change, such as
ambient particulate matter (PM) air pollution. Large epidemiological long-term studies
such as the Six Cities Study (Dockery et al, 1993), the American Cancer Society (ACS)
study (Barnes, 2000), and the Adventist Health and SMOG Study (AHSMOG-1) (Abbey
et al., 1999), have demonstrated an association between ambient particulate matter (PM)
air pollution and all-cause and cardiopulmonary mortality.
Although several epidemiological studies have suggested a link between air
pollutants and risk of death (Abbey et al., 1999; Dockery et al., 1993; Naess, Nafstad,
Aamodt, Claussen, & Rosland, 2007; Pope et al., 2004), to our knowledge, none of these
investigations studies were conducted among COPD and asthmatic patients — a
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potentially susceptible population — to understand whether long-term ambient air
pollution exposure, particulate or gaseous, contributes to an increased risk of all cause
morality among this subpopulation who have never smoked and those who did not
change their address. In addition, we have more subjects in our current database than in
the AHSMOG-1 study which was 6,338 subjects (Abbey, Hwang, Burchette, Vancuren,
& Mills, 1995; Abbey et al., 1999; Beeson, Abbey, & Knutsen, 1998), and we propose
that we have a more accurate measurement tool for air pollution.
The purpose of this study was to assess the effect of chronic exposure to ambient air
pollutants and risk of all-cause mortality among never smoking subjects diagnosed with
either COPD or asthma who did not change their primary residence since enrollment in
the study.
Materials and Methods
Study population
The Adventist Health and Smog (AHSMOG-2) Study began in 2002 as a sub
study of the Adventist Health Study-2 (Butler et al., 2008), a cohort study of about
97,000 subjects from the US and Canada. Subjects living at their US enrollment address
for more than 1 year and who reported a diagnosis of COPD and/or asthma at baseline
were the target population for this study. We excluded persons who had moved away
from their baseline residence ZIP code during follow-up as well as those who had ever
smoked. Thus, our study population consists of 3564 never smoking subjects with
prevalent COPD and/or asthma who did not changed their residence since enrollment.
As part of their enrollment into the AHS-2, subjects completed a comprehensive
50 page questionnaire that included questions on demographics, medical history,
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education, anthropometric data, smoking history, dietary habits, exercise patterns, and
time spent outdoors.
Estimation of ambient air pollution concentrations
PM2.5 and O3 monthly concentration averages (January 1, 2000 to December 31,
2007), were estimated using information from the Aerometric Information Retrieval
Systems (AIRS) database maintained by the U.S. Environmental Protection Agency
(EPA). For each subject’s residence address, cumulative exposure was calculated from
12 months prior to enrollment until one month before censoring. Inverse distance
weighting (IDW) was used to estimate ambient air pollution levels. IDW is a
deterministic interpolation method that assumes that concentrations from stations closer
to location of interest are more influential in the estimation than concentrations from
more distant stations (Watson, 1992). The method depends on monitoring sites that are
weighed by the inverse of their distance from the estimation point. Then the weighted
concentrations are divided by the sum of the weights so that the weights sum to one
(Frank & Horie, 1977). Monthly concentration was interpolated to the geographic
centroids of residential and work/ ZIP codes.
Covariables
Candidate covariables were selected based on a literature search and information
from the baseline questionnaire, including age, gender, race, education, and Body Mass
Index (BMI) Education was classified into three levels (high school or less, some
college or trade school, college graduate or higher). Since this population is members of
a church that proscribes alcohol use, this variable was classified into ever/never. Co
morbidities included angina, myocardial infarction, congestive heart failure, stroke,
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transient ischemic attacks, diabetes mellitus (I or II) and hypertension and were coded as
any or none.
Ascertainment of deaths
Natural causes of death were ascertained through 2009 using record linkage
between the Adventist Health Study-2 (AHS-2) and the National Death Index (CDC .
2010; Martin et ah, 2008).
Statistical analysis
Student t-test and chi-square tests were used to compare the baseline
characteristics between all-cause mortality cases and non-cases. Time-dependent Cox
proportional-hazards regression modeling was used to study the associations between
pollutants (PM2.5, and O3) and all-cause mortality (Greenland, 1989). Using attained age
as the time variable, a basic model was developed with the type of air pollutant (PM2.5,
O3 or both), education, and gender as covariables. Based on our literature review, the
following candidate co-variables were selected: BMI, time spent outdoors, gender,
education, alcohol, race, vegetarian status, exercise, and co-morbidities. These were
entered into the basic multivariable model one at a time to assess their impact on the main
effect. Only time spent outdoors and exercise changed the hazard ratio (HR) > 10% and
were therefore retained in the final model. In addition to the main exposure, we added an
interaction term (to evaluate effect modification) between several variables, but none
were significant and thus not included in the final model.
Both single- and two-pollutant models were used to assess hazard ratios (HRs)
associated with increasing levels of air pollutants. The different pollutants were entered
into the model as continuous variables. HRs were calculated for an increment of 10 pg/m
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for PM2.5 and 10 ppb for O3. To standardize the exposure window preceding events, 1) a
3-year average were selected as the time period of exposure, but excluded the last month
before the event to avoid measuring short-term effects; this range was chosen because
there were few deaths after 3 years; 2) we then calculated the exposure by creating a
cumulative monthly average 12 months prior enrollment until one month before
censoring. Participants who did not die were censored at end of follow-up or at the time
of last contact if they were lost to follow-up.
The proportional hazards assumption was checked by examining log
[-log(survival)] curves versus the time (attained age) variable as well as the product term
of each respective variable in the final model with the log of the time variable
(Greenland, 1989). Each of these interactive terms produced a p-value > 0.05 based on
the Wald statistic, indicating that the proportional hazards assumptions were not seriously
violated. This was supported further by visual inspection. We used the SAS statistical
package (version 9.2; SAS institute, Cary, NC) for all analyses.
Results
There were 102 all-cause deaths during the 3 year, 10 month follow up period
(2002-2007). Those who died were older at baseline, spent less time outdoors, had fewer
years of education, lower levels of physical exercise, were more likely to have one or
more comorbidities, and were more likely to be female (Table 4-1). Frequency
histograms of the individual mean ambient concentrations of PM and O3 from 2000 to
censoring month are given in Figure 4-1 and 4-2. Table 4-2 gives an overview and
frequency of the various diagnoses included among the all-cause mortality outcomes.
Associations with PM? 5
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A significant relationship was found between PM2.5 and all-cause mortality
HR=2.70 [95% (Cl), 1.09-6.65] for each increment of 10 pg/m3 (Table 3). The estimate
remained virtually unchanged but become not significant in the two-pollutant model with
03 (HR=2.23 [95% Cl, 0.99-5.03]).
Associations with ozone
No significant association was found between ambient O3 and all-cause mortality in
single-pollutant models (HR=1.32 [95% Cl, 0.74-2.36] for each increment of 10 ppb
(Table 3). Further adjustment in the two-pollutant model with PM2.5 did not materially
alter this non-significant relationship (HR = 1.33; 95% Cl, 0.79-2.25) (Table 4-3).Using
cumulative monthly averages from 2000 to censoring, the Cox regression gave similar
results, but the point estimates were somewhat weaker (Table 4-4).
Discussion
We found significant relationships between fine particulate matter (PM2.5) and all
cause mortality among COPD and/or asthmatic patients who have never smoked. As
members of a church which proscribes smoking, the Adventist study cohort was probably
exposed to very little environmental cigarette smoke. Thus, this study strongly reduces
any confounding effects of tobacco smoke. To our knowledge, there has been no other
cohort study on the health effects of ambient air pollution among never smokers with
stable residential histories.
Several studies have found an association between ambient PM2.5 - and
cardiopulmonary disease (CPD) or total mortality (Halonen et al., 2010; Naess et al.,
2007; Pope et al., 2002; Pope et al., 2004; Samet, Dominici, Curriero, Coursac, & Zeger,
2000). The Harvard Six Cities study involved a 14-16 year prospective follow up of more
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than 8000 adults in six U.S. cities and controlled for age, sex, cigarette smoking,
education, BMI, and other risk factors (Sullivan et ah, 2005). The adjusted mortality-rate
ratio for the most polluted of the cities as compared with the least polluted for PM2.5 was
1.26 (95 % Cl, 1.08 to 1.47). Air pollution (PM2.5) was positively associated with death
from cardiopulmonary disease in current smokers 2.30 (95 % Cl, 1.56 to 3.41) and most
polluted compared with the least polluted 1.37 (95 % Cl, 1.11 to 1.68). Mortality was
most strongly associated with air pollution with PM.2.5 value (Dockery et al., 1993).
However, air pollution exposure was represented by one average figure for each city so
that only six air pollutant data points were used (Higgins et al., 2003). The effect of fine
particles on CPD mortality has not been reported from AHSMOG to date. For PM10 and
CPD mortality, no significant relationships were found, but males had higher estimates
than females (Abbey et al., 1999).
Pope et al. (1999) conducted the American Cancer Society Study (ACS) to assess
the relationship between long-term exposure to fine particulate air pollution and allcause, lung cancer, and cardiopulmonary mortality (Pope et al., 1999). Each 10 pg/m 3
increase in fine particulate air pollution was associated with approximately a 4%, 6%,
and 8% increased risk of all-cause, cardiopulmonary, and lung cancer mortality,
respectively. In 2009, Jerrett et al., 2009 found that in single-pollutant models increased
concentrations of either PM2.5 or O3 were significantly associated with an increased risk
of death from cardiopulmonary causes (RR=1.129, 95% Cl (1.094-1.071); RR=1.016,
95% CI(1.008-1.024)). In two-pollutant models, PM2.5 was not associated with the risk
of death from respiratory causes (RR=0.927, 95% Cl) (0.836-1.029). A limitation of
ACS was that these subjects were enrolled by volunteers from among their friends and
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relatives, so it is likely that the subjects probably were not representative of the general
population within each city (Higgins et ah, 2003).
In this study we found that PM2.5 has the strongest effect compared with ozone.
PMi.sseems to behave different biologically compare with O3 among this population. One
possible explanation for the higher risk estimates in our study could be more precise
estimates of ambient air pollution and thus less exposure misclassification. The second
reason could be due to characteristics of this subpopulation (COPD and/ or asthma)
which make them more vulnerable. Other reasons could be the homogeneity of the
population with regards to certain personal characteristics (e.g. never smokers) and
among those who did not change their address (see “Strengths and limitations,” below).
The U.S. Environmental Protection Agency (EPA) has suggested that the
observed association between health effect and PM could instead be due to gaseous
pollutants since components of air pollution frequently occur together and are highly
correlated (U.S. EPA, 1989). In our study, the correlation between concentration of PM2.5
and O3 was about 23. We found significant associations between all-cause mortality and
PM2.5 in single- and two-pollutant models. In addition, in the two-pollutant models, O3
strengthened the relationship between PM2.5 and all-cause mortality. The modifying effect
of O3 can possibly be explained by findings indicating that lung epithelial permeability
increases with exposure to O3), thus making the body more susceptible to intrusion of
particulate matter (Blomberg et al., 2003.
Possible biological mechanism
PM2.5 may play the largest role in affecting human health due to its intrinsic
toxicity compared to coarse PM (Pope & Dockery, 2006). Fine particles can be breathed
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more deeply into the lungs, remain suspended for longer periods of time, penetrate more
readily into indoor environments, and are transported over much longer distances (Pope
& Dockery, 2006). A described effect of PM2.5 includes pulmonary and systemic
oxidative stress, inflammation, atherosclerosis, and related cardiovascular disease (Pope
& Dockery, 2006). These mechanisms can lead to death through different pathways. It
starts with inflammation along blood lipid levels, which lead to initiation and progression
of atherosclerosis. In addition, long-term chronic exposure to PM2.5 could be exaggerated
in the case of pulmonary disease since airway inflammation in asthma is characterized by
an eosinophilic inflammation, while in COPD it is characterized by neutrophil (Barnes,
2000). In addition, short-term, elevated exposures to PM and related inflammation may
also contribute to acute thrombotic complications of atherosclerosis, increasing the risk of
making atherosclerotic plaques more vulnerable to rupture, clotting, and precipitating
acute cardiovascular or cerebrovascular events (myocardial infarction or ischemic
stroke). This may increase the risk of mortality among all-cause mortality cases because
it has been reported that cardiovascular disease (CVD) is more frequent in COPD patients
than in the general population and may represent a burden greater than that of lung
disease itself (Huiart, Ernst, & Suissa, 2005). At the same time, systemic inflammation
associated with COPD may contribute to cardiovascular risk by provoking “alveolar
inflammation, with release of mediators, which in susceptible individuals are capable of
causing exacerbations of lung disease and of increasing blood coagulability, thus also
explaining the observed increases in cardiovascular deaths associated with urban
pollution episodes” (Pope & Dockery, 2006).
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O3, which shows a weaker effect in our study, affects the human body though free
radicals that are created through the reaction between ozone and: polyunsaturated fatty
acids, sulfhydryl amino acids, and some electron rich compounds (Kanofsky & Sima,
2000; Leon et ah, 1998). It has been reported that ozone can increase airway
inflammation and airway responsiveness, and also can potentiate the airway response to
inhaled allergens (Bernstein et ah, 2004).
Strengths and limitations
Because all subjects in our investigation are never smokers, our results are free
from the confounding effects of both past and current cigarette smoking. The AHSMOG2 has extensive subject specific factors information which allowed us to adjust for
lifestyle, with all-cause mortality in this cohort as gender, education, and time spent
outdoors were found to be associated. This adjustment actually strengthened the
association between O3 and all-cause mortality. In addition, we conducted our analysis
among subjects with COPD and/or asthma patients, which may show the effect of air
pollution among this particular population.
Although we have shown all-cause mortality of air pollution in this study, there is
an unknown amount of measurement error in both the estimated long-term ambient
concentrations of pollutants and other covariates. One source of measurement error
derives from using interpolating ambient concentrations of pollutants (Abbey et ah,
1995).
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Conclusions
In summary, ambient levels of PM2.5 were found to increase the risk of death
measured level of exposure among subjects with COPD and/or asthma and who are never
smokers. The relationship was stronger than has previously been found by others and
may be due to the fact that this population was a never smoking population and at higher
risk of death due to COPD and/or asthma. Further studies are needed among other never
smoking populations.
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Table 4-1: Selected characteristics of study population who self-reported COPDf and/or
asthma at baseline

Age (Years)
BMI
Time spent outdoor (hours)
PM2.5(|ig/m3)
Ozone ( PPM)
Gender
Education **

Alcohol

Females
Males
HS or less
SC+AD
BD+MD+DOC
No( last
12month)
Yes (last 12
month)
Non-Black
Black
Vegan

Total
(N= 3,666)

(N=102)

Non cases
(N=3,564)

Mean (SD)

Mean (SD)

Mean (SD)

56.58(13.48)
28.53(7.01)
8.63(5.75)
11.64(2.35)
29.56(3.20)

75.64(12.40)
27.16(7.23)
8.59(5.68)
11.89(2.58)
30.38(3.82)

56.03(13.11)
28.57(7.0)
8.07(5.79)
11.64(2.34)
29.53(3.18)

N (%)

N (%)

N (%)

2709(73.9)
957(26.1)
1621(44.7)
1303((35.9)
3395(92.6)

58(56.9)
44(43.1)
42(42.0)
35(35.0)
23(23.0)
101(99.0)

2651(74.4)
913(25.6)
1579(44.7)
1268(35.9)
683(19.4)
3294(92.4)

271(7.4)

1(1.0)

270(7.6)

706(20.4)

Cases

p- value

<0.0001
0.0451
8.60(5.68)
0.3022
0.0301
<0.0001
0.6531

0.0121

2722(76.4)
0.0895
85(83.3)
2807(76.6)
859(23.4)
842(23.6)
17(16.7)
214(6.0)
Vegetarian
9(8.8)
223(6.1)
0.1009
Status
40(39.2)
1048(29.4)
Lacto
1088(29.7)
325(9.1)
Pesco
10(9.8)
335(9.1)
222(6.2)
Semi
227(6.2)
5(4.9)
1755(49.2)
None
1793(48.9)
38(37.3)
1555(43.6)
Exercise
Low
<0.0001
1579(43.1)
24(23.6)
1282(36.0)
39(38.2)
1321(36.0)
Moderate
39(38.2)
727(20.4)
High
766(20.9)
BMI
10-24.9
25(24.8)
0.0468
1191(33.5)
1216(33.3)
1148(32.3)
1178(32.2)
25-29.9
30(29.7)
1216(34.2)
30-59.9
1262(34.5)
46(45.5)
657(18.4)
701(19.1)
44(43.1)
CoYes
<0.0001
morbidities*** No
2907(81.6)
2965(80.9)
58(56.9)
*cases are those who died due to all-cause mortality.
**HS (high school), SC (some college), AD (associate degree), BD (bachelor degree), MD
(master degree) and DOC (doctoral degree).
***Angina, Myocardial infarction, congestive heart failure, stroke, transient ischemic
attacks, diabetes mellitus (I or II) and hypertension,
f Chronic obstructive pulmonary disease
Race
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Table 4-2: Frequencies of causes of death under all-cause mortality cases (N=102)
causes of death

N

Malignant neoplasms

31

Ischemic heart diseases

16

Chronic lower respiratory diseases

9

Other forms of heart disease

8

Cerebrovascular diseases

8

Diseases of the genitourinary system

5

Stroke, not specified as hemorrhage or infarction

3

Diseases of the digestive system

3

Diabetes mellitus

3

Diseases of arteries, arterioles and capillaries

2

Bacterial diseases

2

Pneumonia

2

Diseases of the nervous system

2

Heart failure

1

Hypertensive diseases

1

Pulmonary heart disease and diseases of pulmonary circulation

1

Senility

1

Malnutrition

1

Disorders involving the immune mechanism

1

Disorders of the skin and subcutaneous tissue

1

Acute appendicitis

1

Total

102
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Table 4-3: Hazard ratio of total death among AHS-2 study subjects who self-reported
CORD* according to increments of long-term concentrations of PM2.5 and ozone (20002007): single & two pollutant models. Air pollution method used is IDW Moving average
method 36 months
Model
Variable
HR (95% Cl)
Single pollutant
PM2.5 (A10|ig/m3)
2.7 (1.09-6.65)
Gender
Female
1
Male
2.49 (1.54-4.03)
Education
HS or less
1.34 (0.74-2.42)
SC+AD
1.20 (0.67-2.16)
BD+MD+DOC
1
Time outdoors
0.61 (0.34-1.11)
Calendar time
1.10 (0.94-1.28)
Race
Non Black
1
Black
1.19 (0.62-2.26)
Exercise
Low
1
Moderate
0.89 (0.53-1.48)
Single pollutant
High
0.61 (0.34-1.10)
Ozone(A10 ppb)
1.32 (0.74-2.36)
Gender
Female
1
Male
2.54(1.56-4.12)
Education
HS or less
1.34 (0.74-2.43)
SC+AD
1.17 (0.65-2.12)
BD+MD+DOC
1
Calendar time
1.09 (0.93-1.28)
Time outdoors
0.97 (0.93-1.01)
Race
Non Black
1
Black
1.46 (0.76-2.78)
Exercise
Low
1
Moderate
0.86 (0.52-1.43)
High
0.58 (0.32-1.06)
Two pollutants
PM2 5 (Aldug/m3)
2.23 (0.99-5.03)
Ozone(A10 ppb)
1.33 (0.79-2.25)
Gender
Female
1
Male
2.52 (1.63-3.92)
Education
HS or less
1.09 (0.65-1.83)
SC+AD
0.82 (0.49-1.39)
BD+MD+DOC
1
Outdoor time
0.97 (0.94-1.01)
Race
Non Black
1
Black
1.27 (0.66-2.53)
Exercise
Low
1
Moderate
0.80 (0.50-1.27)
High
0.56 (0.32-0.96)
*Chronic obstructive pulmonary disease
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Table 4-4: Hazard ratio of total death among AHS-2 study subjects who self-reported
CORD* according to increments of long-term concentrations of PM2.5 and ozone (20002007): single & two pollutant models. Air pollution used is IDW accumulation method 12
months
Model
Variable
HR (95% Cl)
Single pollutant
PM2.5 (AlOpg/mB)
2.29 (1.00-5.20)
Gender
Female
1
Male
2.51 (1.55-4.07)
Education
HS or less
1.32 (0.73-2.38)
SC+AD
1.17 (0.65-2.10)
BD+MD+DOC
1
Time outdoors
0.97 (0.93-1.01)
Calendar time
1.09 (0.93-1.27)
Race
Non Black
1
Black
1.25 (0.66-2.37)
Exercise
Low
1
Moderate
0.90 (0.54-1.49)
Single pollutant
High
0.62 (0.34-1.12)
Ozone(A10 PPM)
1.26(0.76-2.10)
Gender
Female
1
Male
2.54(1.57-4.13)
Education
HS or less
1.34 (0.74-2.44)
SC+AD
1.17 (0.65-2.12)
BD+MD+DOC
1
Calendar time
1.09 (0.93-1.28)
Time outdoors
0.97 (0.93-1.01)
Race
1
Non Black
Black
1.45 (0.76-2.75)
Exercise
Low
1
Moderate
0.86 (0.52-1.44)
High
0.58 (0.32-1.06)
Two pollutants
PM2.5 (A10pg/m3)
2.18 (0.94-5.10)
Ozone(A10 PPM)
1.12 (0.66-1.88)
Gender
Female
1
Male
2.53 (1.56-4.11)
Education
HS or less
1.31 (0.72-2.36)
SC+AD
1.15 (0.63-2.07)
Calendar time
Time outdoors
Race
Exercise

BD+MD+DOC

1

Non Black

1.09 (0.93-1.27)
0.97 (0.93-1.01)
1

Black

1.29 (0.67-2.47)

Low
Moderate
High

1
0.90 (0.54-1.50)
0.62 (0.34-1.12)
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*Chronic obstructive pulmonary disease
Figure 4-1: Frequency distribution of mean ambient concentration of PM2.5 2000 to
censoring month
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Figure 4-2: Frequency distribution of mean ambient concentration of O3 2000 to
censoring month
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CHAPTER 5
OTHER FINDINGS

A. O3 and different moving average/accumulation/ time independent methods:
We used different moving averages from 12 months up to 60 months, excluding
the last month before the event to evaluate the long term effect; we also used a 24 month
accumulation method(24 months of exposure before study start), and time independent
analysis, which means we did not include time-to-event in our analysis. Put another way,
a subject who died in 2005 or 2006, would not affect our analysis, and the data would be
treated in the way. This model helped us to determine the relationship between non
cancer respiratory mortality and increments of long-term concentrations of PM2.5 and O3
from 2002 to 2007. Overall, as can be seen from Tables 5-1 to 5-6, the point estimate saw
little change and showed consistently significant results with 63, whereas the association
with PM2.5 was not as clear.

Tables 5-1: Hazard ratio of non-cancer respiratory mortality according to increments of
long-term concentrations of PM2.5 and ozone (2002-2007): Single & two pollutant
models. Air pollution method used is IDW moving average (12 months).
Single Pollutant
Two Pollutants
Adjusted
event
Ozone
Ozone
PM2.5
PM2.5
(10pg/m3)
for
(10pg/m3)
(10PPB)
(10PPB)
Gender +
247
0.94
1.96
1.03
1.96
education
(0.56-1.58)
(1.37-2.8)
(0.61-1.74)
(1.37-2.81)
as a basic
model
+ Time
216
0.82
2.04
0.92
2.03
spent
(0.47-1.43)
(1.39-2.99)
(0.53-1.59)
(1.38-2.98)
outdoors
+ Exercise 216
2.04
0.78
2.02
0.87
(0.44-1.36)
(1.39-2.98)
(0.5-1.51)
(1.38-2.96)
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Tables 5-2: Hazard ratio of non-cancer respiratory mortality according to increments of
long-term concentrations of PM2.5 and ozone (2002-2007): Single & two pollutant
models. Air pollution method used is IDW moving average (24 months).
Single Pollutant
Two Pollutants
Adjusted
event
Ozone
Ozone
PM2.5
PM2.5
(10pg/m3)
(10pg/m3)
for
(10PPB)
(10PPB)
1.99
Gender +
247
0.98
1.99
1.09
education
(0.65-1.82)
(1.4-2.83)
(1.4-2.82)
(0.59-1.65)
as a basic
model
2.08
+ Time
2.09
0.96
216
0.85
spent
(0.49-1.48)
(1.43-3.04)
(0.55-1.66)
(1.43-3.03)
outdoors
+ Exercise 216
0.9
2.07
0.8
2.09
(1,43-3.04)
(0.46-1.4)
(0.52-1.56)
(1.42-3.03)

Tables 5-3: Hazard ratio of non-cancer respiratory mortality according to increments of
long-term concentrations of PM2.5 and ozone (2002-2007): Single & two pollutant
models. Air pollution method used is IDW moving average (48 months).
Two Pollutants
Single Pollutant
Ozone
Adjusted
event
Ozone
PM2.5
PM2.5
(10pg/m3)
(10pg/m3)
(10PPB)
for
(10PPB)
1.12
Gender +
247
1.05
1.96
1.97
education
(0.68-1.84)
(1.41-2.75)
(0.64-1.73)
(1.4-2.75)
as a basic
model
2.04
1
0.92
2.04
+ Time
216
spent
(0.54-1.57)
(1.42-2.93)
(0.59-1.69)
(1.42-2.93)
outdoors
+ Exercise 216
0.87
2.05
0.93
2.05
(0.51-1.48)
(1.43-2.95)
(0.55-1.59)
(1.43-2,95)
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Tables 5-4: Hazard ratio of non-cancer respiratory mortality according to increments of
long-term concentrations of PM2.5 and ozone (2002-2007): Single & two pollutant
models. Air pollution method used is IDW moving average (60 months).
Single Pollutant
Two Pollutants
Adjusted
event
Ozone
Ozone
PM2.5
PM2.5
(10pg/m3)
(10pg/m3)
for
(10PPB)
(10PPB)
1.14
1.98
Gender +
247
1.09
1.97
education
(0.67-1.77)
(1.41-2.75)
(0.7-1.86)
(1.42-2.75)
as a basic
model
1.02
2.06
+ Time
216
0.96
2.06
spent
(0.61-1.71)
(0.57-1.61)
(1.44-2.94)
(1.44-2.94)
outdoors
+
0.96
2.07
216
0.9
2.07
(1.45-2,96)
(0.54-1,52)
(0.57-1.61)
Exercise*
(1.45-2.95)

Tables 5-5: Hazard ratio of non-cancer respiratory mortality according to increments of
long-term concentrations of PM2.5 and ozone (2002-2007): Single & two pollutant
models. Air pollution method used is IDW time independent.
Single Pollutant
Two Pollutants
Ozone
Adjusted
event
Ozone
PM2.5
PM2.5
(10pg/m3)
(10pg/m3)
for
(10PPB)
(10PPB)
1.72
1.05
Gender +
247
1.25
1.73
(0.81-1.94)
education
(1.31-2.30)
(0.67-1.63)
(1.29-2.30)
as a basic
model
+ Time
216
1.16
1.80
0.97
1.81
spent
(0.73-1.85)
(1.33-2.44)
(0.61-1.55)
(1.32-2.48)
outdoors
+
1.84
216
1.109
1.81
0.91
Exercise*
(0.70-1.77)
(1.34-2,46)
(0.57-1.47)
(1.34-2.52)
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Tables 5-6: Hazard ratio of non-cancer respiratory mortality according to increments of
long-term concentrations of PM2.5 and ozone (2002-2009): Single & two pollutant
models. Air pollution method used is IDW time independent.
Single Pollutant
Two Pollutants
Adjusted
event
Ozone
Ozone
PM2.5
PM2.5
for
(10pg/m3)
(10pg/m3)
(10PPB)
(10PPB)
Gender +
247
1.311
1.579
1.146
1.547
education
(0.931-1.845) (1.262-1.978)
(0.812-1.619)
(1.229-1.95)
as a basic
model
+ Time
216
1.269
1.644
1.094
1.622
spent
(0.883-1.824) (1.296-2.085)
(0.758-1.577)
(1.270-2.07)
outdoors
+
216
1.231
1.658
1.05
1.645
Exercise*
(0.855-1.772)
(1.307-2.104)
(0,728-1.520)
(1.288-2,10)

B. Non-cancer respiratory mortality among Whites only
The same study was conducted using only white subjects; moving average and the
accumulation method was used to determine the relationship between non-cancer
respiratory mortality and increments of long-term concentration of PM2.5 and ozone from
2002 to 2007. Significant relationships were found between O3 and non-cancer
respiratory mortality similar to what we found in the overall population. Limiting our
study population to never smokers eliminated the confounding effect of smoking on the
data. In the previous analysis (Table 5-1 to 5-6), we included all subject data with
smoking as one of the covariates.
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Table 5-7: Baseline characteristics of emphysema, bronchitis, asthma or pneumonia cases
and non-cases among white AHS-2 study subjects.
Variable
Total
Cases*
Non cases
p- value
(N=35770)
(N=230)
(N=35540)
Mean (SD)
Mean (SD)
Mean (SD)
Age (years)
59.81(13.93) 78.97(12.00) 59.68(13.85)
<0.0001
BMI
26.43(5.58) 25.18(5.49) 26.44(5.58)
0.0008
Time spent outdoors (hours)
9.07(6.00)
7.83 (6.65)
9.08 (5.60)
0.0086
PM2.5(pg/m3)
11.40(2.38)
11.45(2.43) 11.40(2.38)
0.7551
Ozone (PPB)
29.87(3.07)
30.81(3.53) 29.86(3.06) <0.0001***
N (%)
N (%)
N (%)
Gender
116(50.4)
Females
23788(66.5)
23672(66.6)
<0.000
11868(33.4)
Males
11982(33.5)
114(49.6)
Education**
7600(21.6)
HS or less
7679(21.7)
79(34.8)
<0.0001
SC+AD
11829(36.2)
11755(33.4)
74(32.6)
74(32.6)
BD+MD+DOC 16121(45.1)
15816(45.0)
224(97.4)
Alcohol
No( last
33243(92.9)
33019(92.9)
0.0081
12month)
Yes (last 12
2527(7.1)
6(2.6)
2521(7.1)
month)
Vegetarian
Vegetarian
16858(47.1)
125(54.3)
<0.0278
16733(47.1)
Status
Non
18912(52.9)
105(45.7)
18807(52.9)
Exercise
Low
120(52.2)
6714(18.8)
6594(18.6)
<0.0001
Moderate
12935(36.2)
12876(34.2)
59(25.7)
16070(45.2)
High
51(22.2)
16121(45.1)
15418(45.4)
BMI
15540(45.5)
10-24.9
122(54.7)
0.0069
11648(34.1)
11577(34.1)
25-29.9
71(31.8)
6995(20.4)
30-59.9
30(13.5)
5965(20.5)
CoNo
30483(85.2)
30338(85.4)
145(63.0)
<0.0001
morbidities §
*cases are those who died due to all-cause mortality.
**HS (high school), SC (some college), AD (associate degree), BD (bachelor degree), MD
(master degree) and DOC (doctoral degree).
§Angina, Myocardial infarction, congestive heart failure, stroke, transient ischemic attacks,
diabetes mellitus (I or II) and hypertension.
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Tables 5-8: Hazard ratio of non-cancer respiratory mortality according to increments of
long-term concentrations of PM2.5 and ozone among whites (2002-2007): Single & two
pollutant models. Air pollution method used is IDW accumulation (12 months).
Single Pollutant
Two Pollutants
Adjusted
event
Ozone
Ozone
PM2.5
PM2.5
(10pg/m3)
for
(10pg/m3)
(10 PPB)
(10 PPB)
Gender +
222
1.22
1.24
1.59
1.59
education
(0.72-2.05)
(1.11-2.28)
(1.12-2.28)
(0.74-2.09)
as a basic
model
+ Outdoor
1.04
195
1.66
1.08
1.66
time
(0.6-1.81)
(1.13-2,44)
(0.62-1.87)
(1.13-2.44)

Tables 5-9: Hazard ratio of non-cancer respiratory mortality according to increments of
long-term concentrations of PM2.5 and ozone among whites (2002-2007): Single & two
pollutant models. Air pollution method used is IDW moving average (48 months).
Single Pollutant
Two Pollutants
Adjusted
event
Ozone
PM2.5
Ozone
PM2.5
for
(10pg/m3)
(10pg/m3)
(10 PPB)
(10 PPB)
Gender +
222
1.74
1.24
1.74
1.23
education
(0.75-2.02)
(1.23-2.48)
(0.76-2.04)
(1.23-2.47)
as a basic
model
+ Outdoor
195
1.07
1.84
1.84
1.09
time
(0.63-1.8)
(1.26-2,68)
(0.64-1.84)
(1.26-2,68)

C. The association between PM2.5 and different moving average/accumulation/time
independent methods on total mortality among persons with prevalent COPD:
We used different moving averages from 12 months up to 60 months,
accumulation methods of 24 months, and time independent analysis to determine the
relationship between total death among self-reported COPD cases according to
increments of short-term concentrations of PM2.5 and ozone, which include the last month
before death from 2002 to 2007. Overall, the point estimate saw little change and showed
significant results with PM2.5.
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Short term effect:

Tables 5-10: Hazard ratio of total death among AHS-2 study subjects who self-reported
COPD* according to increments of short-term concentrations of PM2.5 and ozone (20022007): Single & two pollutant models. Air pollution method used is IDW.
Single Pollutant
Two Pollutants
Ozone
Ozone
Adjusted
event
PM2.5
PM2.5
(10pg/m3)
(10pg/m3)
(10PPB)
for
(10PPB)
Gender +
1.54
1.66
1.17
115
1.1
(1.09-2.52)
(0.93-1.46)
education
(0.88-1.37)
(1.02-2.32)
as a basic
model
1.42
104
1.32
1.12
1.17
+ Time
(0.85-2.06)
(0.89-1.41)
(0.9-2.23)
(0.92-1.48)
spent
outdoors
104
1.12
1.4
1.17
+ Exercise
1.3
(0.89-2.21)
(0.92-1.48)
(0.84-2.03)
(0.89-1.41)
* Chronic obstructive pulmonary disease

Lons term effect:

Tables 5-11: Hazard ratio of total death among AHS-2 study subjects who self-reported
COPD* according to increments of long-term concentrations of PM2.5 and ozone (20022007): Single & two pollutant models. Air pollution method used is IDW accumulation
(12 months),
Two Pollutants
Single Pollutant
Ozone
Adjusted
event
Ozone
PM2.5
PM2.5
(10pg/m3)
(10PPB)
(10pg/m3)
(10PPB)
for
1.36
Gender +
2.87
115
2.73
1.27
education
(1.31-6.26)
(0.84-2.21)
(1.25-5.96)
(0.77-2.09)
as a basic
model
104
1.21
1.26
+ Time
2.37
2.43
(1.05-5.34)
(0.71-2.05)
(1.08-5.47)
(0.75-2.12)
spent
doors
1.21
2.32
1.26
104
+ Exercise
2.26
(1.03-5.24)
(0.75-2,11)
(1-5.12)
(0.71-2.06)
* Chronic obstructive pulmonary disease
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Tables 5-12: Hazard ratio of total death among AHS-2 study subjects who self-reported
COPD* according to increments of long-term concentrations of PM2.5 and ozone (20022007): Single & two pollutant models. Air pollution method used is IDW accumulation
(24 months).
Single Pollutant
Two Pollutants
Gender +
115
2.64
1.34
1.29 (0.792.71
education
(1.24-5.65)
(1.27-5.77)
(0.83-2.19)
2.13)
as a basic
model
+ Time
104
2.32
1.24
2.34
1.25
spent
(1.05-5.11)
(0.73-2.1)
(0.75-2.11)
(1.07-5.14)
outdoors
104
+ Exercise
2.21
1.24
2.23
1.25
(1-4,89)
(0.73-2.1)
(1.01-4.91)
(0.74-2.1)
* Chronic obstructive pulmonary disease

Tables 5-13: Hazard ratio of total death among AHS-2 study subjects who self-reported
COPD* according to increments of long-term concentrations of PM2.5 and ozone (20022007): Single & two pollutant models. Air pollution method used is IDW moving average
(12 months).
Single Pollutant
Two Pollutants
event
Adjusted
Ozone
Ozone
PM2.5
PM2.5
for
(10pg/m3)
(10pg/m3)
(10PPB)
(10PPB)
Gender +
115
2.73
1.27
2.71
1.46
education
(1.25-5.96)
(0.77-2.09)
(1.22-6)
(0.87-2.45)
as a basic
model
+ Time
104
1.21
2.37
2.27
1.35
spent
(1.05-5.34)
(0.71-2.05)
(0.99-5.23)
(0.78-2.33)
outdoors
+ Exercise
104
2.26
1.21
2.17
1.34
(1-5.12)
(0.71-2.06)
(0.94-5)
(0.77-2.33)
* Chronic obstructive pulmonary disease
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Tables 5-14: Hazard ratio of total death among AHS-2 study subjects who self-reported
COPD* according to increments of long-term concentrations of PM2.5 and ozone (20022007): Single & two pollutant models. Air pollution method used is IDW moving average
(24 months).
Single Pollutant
Two Pollutants
Ozone
Ozone
Adjusted
event
PM2.5
PM2.5
(lOpg/m3)
(10PPB)
(10pg/m3)
(10PPB)
for
2.64
1.56
3.23
Gender +
1.29
115
(1.45-7.19)
(0.94-2.59)
education
(0.79-2.13)
(1.24-5.65)
as a basic
model
1.24
1.43
104
2.32
2.67
+ Time
(1.16-6.14)
(0.83-2.45)
(1.05-5.11)
(0.73-2.1)
spent
outdoors
1.42
2.52
104
2.21
1.24
+ Exercise
(1.09-5.83)
(0.83-2.44)
(0.73-2.1)
(1-4.89)
* Chronic obstructive pulmonary disease

Tables 5-15: Hazard ratio of total death among AHS-2 study subjects who self-reported
COPD* according to increments of long-term concentrations of PM2.5 and ozone (20022007): Single & two pollutant models. Air pollution method used is IDW moving average
(36 months)
Two Pollutants
Single Pollutant
Ozone
Ozone
Adjusted
event
PM2.5
PM2.5
(10pg/m3)
(10PPB)
(10pg/m3)
(10PPB)
for
1.45
Gender +
1.33
2.9
115
2.66
(1.31-6.41)
(0.88-2.39)
(1.25-5.66)
(0.82-2.18)
education
as a basic
model
1.34
2.41
+ Time
104
1.27
2.39
(1.06-5.5)
(0.79-2.28)
(1.09-5.25)
spent
(0.76-2.15)
outdoors
1.33
104
2.27
+ Exercise
2.28
1.28
(0.99-5.2)
(0.78-2.27)
(1.04-5.02)
(0.76-2.16)
* Chronic obstructive pulmonary disease
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Tables 5-16: Hazard ratio of total death among AHS-2 study subjects who self-reported
COPD* according to increments of long-term concentrations of PM2.5 and ozone (20022007): Single & two pollutant models. Air pollution method used is IDW moving average
(48 months).
Single Pollutant
Two Pollutants
Ozone
Adjusted
event
Ozone
PM2.5
PM2.5
(10pg/m3)
(10PPB)
(10jig/m3)
for
(10PPB)
Gender +
115
2.75
1.45
2.6
1.35
education
(1.24-5.47)
(0.82-2.2)
(1.26-5.99)
(0.89-2.37)
as a basic
model
1.34
104
2.34
2.37
+ Time
1.29
(1.05-5.32)
(0.8-2.26)
spent
(1.08-5.09)
(0.77-2.17)
outdoors
+ Exercise
104
2.24
2.23
1.33
1.29 (0.76(1.03-4,87)
2.18)
(0.99-5.03)
(0.79-2,25)
* Chronic obstructive pulmonary disease

Tables 5-17: Hazard ratio of total death among AHS-2 study subjects who self-reported
COPD* according to increments of long-term concentrations of PM2.5 and ozone (20022007): Single & two pollutant models. Air pollution method used is IDW moving average
(60 months).
Single Pollutant
Two Pollutants
Adjusted
event
Ozone
Ozone
PM2.5
PM2.5
(10pg/m3)
(10pg/m3)
(10PPB)
for
(10PPB)
Gender +
2.64
1.34
1.44
115
2.7
education
(0.89-2.34)
(1.26-5.8)
(1.26-5.55)
(0.82-2.2)
as a basic
model
1.34
104
+ Time
2.39
1.29
2.36
(0.8-2.25)
(1.07-5.22)
spent
(1.1-5.19)
(0.77-2.17)
outdoors
1.34
+ Exercise 104
2.23
2.28
1.29
(1.05-4.96)
(0.77-2.18)
(1.01-4,95)
(0.8-2.24)
* Chronic obstructive pulmonary disease
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Tables 5-18: Hazard ratio of total death among AHS-2 study subjects who self-reported
COPD* according to increments of long-term concentrations of PM2.5 and ozone (20022007): Single & two pollutant models. Air pollution method used is IDW time
independent.
Single Pollutant
Two Pollutants
Adjusted
event
Ozone
Ozone
PM2.5
PM2.5
(10ng/m3)
for
(10pg/m3)
(10 PPB)
(10PPB)
Gender +
115
2.47
1.33
2.33
1.21
education
(1.22-4.99)
(0.86-2.06)
(1.14-4.75)
(0.78-1.86)
as a basic
model
+ Time
104
2.33
1.31
2.20
1.18
spent
(1.12-4.86)
(0.83-2.08)
(1.04-4.65)
(0.74-1.87)
outdoors
+ Exercise
104
2.19
1.31
2.07
1.18
(1.05-4.58)
(0.83-2.06)
(0.98-4.39)
(0.74-1.87)
* Chronic obstructive pulmonary disease

D. Total death among subjects who self-reported COPD among white only
The same study was conducted using only white subjects; moving average and the
accumulation method were used to determine the relationship between total death among
self-reported COPD subjects and increments of long-term concentrations of PM2.5 and
ozone from 2002 to 2007. A robust and significant relationship was found between PM2.5
and total death, similar in magnitude to that found in the total population. As in the
analyses of the total population, we avoided the effect of smoking by limiting our study
population to never smokers.
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Table 5-19: Baseline characteristics of cases* and non-cases among white AHS-2 study
subjects who self-reported COPDf
Variable
Total
Cases
Non cases
p- value
(N=3021)
(N=T02)
(N=2919)
Mean (SD)
Mean (SD)
Mean (SD)
Age (Years)
58.02(13.47) 76.37(12.13) 57.38(13.06) <0.0001§
BMI
28.03(6.85) 26.72(6.53) 28.07(6.89)
0.0599
Time spent outdoor (hours)
8.49(5.63)
8.11(6.10)
8.50(5.61)
0.5012§
PM2.5(pg/m3)
11.32(2.39) 11.60(2.58) 11.31(2.38)
0.2368
Ozone (PPB)
29.96(3.24) 30.54(3.67) 29.94(3.22)
0.0644§
N (%)
N (%)
N (%)
Gender
Females
2108(72.2)
2164(71.6)
56 (54.9)
<0.0001 §
Males
857(28.4)
46(45.1)
811(27.8)
Education **
HS or less
579(19.3)
553(19.1)
26(25.7)
0.2464
SC+AD
1067(35.6)
34(33.7)
1033(35.7)
BD+MD+DOC 1350(45.1)
1309(45.2)
41(40.6)
Alcohol
No( last
2787(92.3)
101(99.0)
2686(92.0)
0.0093§
12month)
Yes (last 12
234(7.7)
1(1.0)
233(8.0)
month)
Vegetarian
Vegetarian
1231(40.8)
55(53.9)
1176(40.3)
0.0059§
Status
Non
1790(59.2)
47(46.1)
1743(59.7)
Vegetarian
Exercise
Low
619(20.5)
38(37.2)
581(19.9)
<0.0001§
Moderate
1109(36.7)
37(36.3)
1072(36.7)
High
1266(43.4)
1293(42.8)
27(26.5)
BMI
10-24.9
1046(37.4)
1090(37.7)
44(45.8)
0.1681
25-29.9
897(32.1)
927(32.0)
30(31.3)
30-59.9
877(30.3)
22(22.9)
855(30.7)
Co
Yes
47(46.1)
566(18.7)
519(17.8)
<0.0001 §
morbidities***
*cases are those who died due to all-cause mortality.
**HS (high school), SC (some college), AD (associate degree), BD (bachelor degree), MD
(master degree) and DOC (doctoral degree).
***Angina, Myocardial infarction, congestive heart failure, stroke, transient ischemic
attacks, diabetes mellitus (I or II) and hypertension,
f Chronic Obstructive Pulmonary Disease
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Tables 5-20: Hazard ratio of total death among white AHS-2 study subjects who selfreported COPD* according to increments of long-term concentrations of PM2.5 and ozone
(2002-2007): single & two pollutant models. Air pollution method used is IDW
accumulation (12 months).
Single Pollutant
Two Pollutants
Adjusted
event
Ozone
PM2.5
Ozone
PM2.5
for
(10pg/m3)
(10pg/m3)
(10 PPB)
(10PPB)
Gender +
98
2.47
1.17
1.21
2.51
education
(1.07-5.69)
(0.67-2.04)
(0.7-2.08)
(1.09-5.78)
as a basic
model
+ Time
91
2.16
1.09
2.16
1.11
spent
(0.92-5.07)
(0.61-1.95)
(0.92-5.08)
(0.62-1.96)
outdoors
+ Co
91
2.35
1.14
2.38
1.17
morbidity
(1-5.54)
(0.63-2.05)
(1.01-5.6)
(0.66-2.09)
+ BMI
86
2.84
1.22
1.24
2.87
(1.17-6.92)
(0.67-2.22)
(1.18-6.97)
(0.69-2.24)
* Chronic obstructive pulmonary disease

Tables 5-21: Hazard ratio of total death among White AHS-2 study subjects who selfreported COPD* according to increments of long-term concentrations of PM2.5 and ozone
(2002-2007): single & two pollutant models. Air pollution method used is IDW moving
average (48 months).
Single Pollutant
Two Pollutants
Adjusted
event
Ozone
Ozone
PM2.5
PM2.5
for
(10pg/m3)
(10pg/m3)
(10 PPB)
(10 PPB)
Gender +
98
2.37
1.28
2.35
1.33
education
(1.07-5.23)
(0.75-2.21)
(1.02-5.38)
(0.77-2.29)
as a basic
model
+ Time
91
2.15
1.21
2.07
1.22
spent
(0.95-4.85)
(0.68-2.13)
(0.69-2.17)
(0.88-4.84)
outdoors
+ Co
91
2.31
2.24
1.26
1.29
morbidity
(1.03-5.22)
(0.71-2.23)
(0.96-5.27)
(0.73-2.3)
+ BMI
86
2.83
1.32
1.34
2.73
(1.21-6.58)
(0.74-2.37)
(1.13-6.6)
(0.75-2.41)
* Chronic obstructive pulmonary disease
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Tables 5-22: Hazard ratio of total death among white AHS-2 study subjects who selfreported COPD* according to increments of long-term concentrations of PM2.5 and ozone
(2002-2007): single & two pollutant models. Air pollution method used is IDW time
independent.
Single Pollutant
Two Pollutants
Adjusted
event
Ozone
Ozone
PM2.5
PM2.5
(10pg/m3)
(10pg/m3)
for
(10 PPB)
(10 PPB)
Gender +
1.04
98
2.44
2.48
1.198
education
(1.12-5.52)
(0.72-1.97)
(0.62-1.73)
(1.08-5.58)
as a basic
model
91
2.34
1.06
+ Time
2.40
1.23
spent
(1.09-5.30)
(0.74-2.04)
(1.03-5.31)
(0.63-1.78)
outdoors
1.12
+ Co
91
2.68
128
2.58
morbidity
(1.20-5.98)
(0.77-2,15)
(1.13-5.87)
(0.66-1.87)
+ BMI
1.12
86
2.69
1.30
2.58
(1.21-6.00)
(0.78-2.17)
(1.13-5.88)
(0.67-1.88)
* Chronic obstructive pulmonary disease
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CHAPTER 6
CONCLUSION

A. Summary of Findings and Implications for Future Research
To our knowledge, no other cohort study on the health effects of ambient air
pollution has reported health outcomes among never smokers who have lived at the same
residence throughout follow-up. Therefore, we cannot readily compare our findings with
other researchers’.
Significant relationships were found between ambient levels of ozone and non
cancer respiratory mortality. Our study also found a positive relationship between
ambient levels of PM2.5 and total mortality among subjects with prevalent COPD and/or
asthma.
The strong effects of particulate air pollution on mortality risk among subjects
with COPD and/or asthma suggests that this is a sensitive population that should
carefully choose their place of residence.
Overall, we found relatively high effect estimates for both (PM2.5 and O3)
compared to what has been reported in other studies. A possible reason for this is that the
Adventists are health conscious and thus relatively “clean” in terms of habits such as
drugs, alcohol and smoking, which are major confounders when studying chronic disease
and mortality. Further, the fact that we limited our analytic population to never smokers
who have not moved during follow-up would be expected to further isolate the
independent effects of ambient air pollution. Thus, we believe that our findings robust
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measure of the actual health effects of ambient air pollution. Further studies among
similar non-smoking, health awareness populations are needed.
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